STRATEGY STUDIO / NONPROFIT PEOPLE SEARCH

VERSITI BLOOD HEALTH INC: Form 990, tax year 2024

View the entire original 990 at ProPublica ↗

Organization
VERSITI BLOOD HEALTH INC (EIN 39-0807235)
Tax period
2024-01-01 to 2024-12-31
Filed
2025-11-11
IRS object ID
202513159349304706
Schema version
2024v5.2
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2025-11-11T13:48:00-06:00ReturnTs
Tax Period End2024-12-31TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

FieldValueIRS element (for citing)
Preparer Firm EIN991856619PreparerFirmEIN

Preparer Firm Name PreparerFirmName

FieldValueIRS element (for citing)
Business Name Line1GRANT THORNTON ADVISORS LLCBusinessNameLine1Txt

Preparer US Address PreparerUSAddress

FieldValueIRS element (for citing)
Address Line153 STATE STREET SUITE 1600AddressLine1Txt
CityBOSTONCityNm
State AbbreviationMAStateAbbreviationCd
ZIP02109ZIPCd
FieldValueIRS element (for citing)
Return Type990ReturnTypeCd
Tax Period Begin2024-01-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN390807235EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1VERSITI WISCONSIN INCBusinessNameLine1Txt
FieldValueIRS element (for citing)
Business Name ControlVERSBusinessNameControlTxt
Phone4149335000PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line1PO BOX 2178AddressLine1Txt
CityMILWAUKEECityNm
State AbbreviationWIStateAbbreviationCd
ZIP532012178ZIPCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonCHRIS MISKELPersonNm
Person TitlePRESIDENT & CEOPersonTitleTxt
Phone4149335000PhoneNum
Signature2025-11-11SignatureDt
Discuss With Paid PreparerYes (1)DiscussWithPaidPreparerInd
FieldValueIRS element (for citing)
IRS Responsible Prty Info Curr0IRSResponsiblePrtyInfoCurrInd

Preparer Person PreparerPersonGrp

FieldValueIRS element (for citing)
Preparer PersonERIN COUTUREPreparerPersonNm
PTINP01390592PTIN
Phone6177237900PhoneNum
FieldValueIRS element (for citing)
Tax2024TaxYr
Build TS2025-03-06 01:10:19ZBuildTS

Form 990 IRS990

FieldValueIRS element (for citing)
Principal OfficerCHRIS MISKELPrincipalOfficerNm

US Address USAddress

FieldValueIRS element (for citing)
Address Line1PO BOX 2178AddressLine1Txt
CityMILWAUKEECityNm
State AbbreviationWIStateAbbreviationCd
ZIP532012178ZIPCd
FieldValueIRS element (for citing)
Gross Receipts$303,566,482GrossReceiptsAmt
Group Return For Affiliates0GroupReturnForAffiliatesInd
Organization501c3Yes (X)Organization501c3Ind
Website AddressWWW.VERSITI.ORGWebsiteAddressTxt
Type Of Organization CorpYes (X)TypeOfOrganizationCorpInd
Formation1947FormationYr
Legal Domicile StateWILegalDomicileStateCd
Activity Or Mission(SEE SCHEDULE O)ActivityOrMissionDesc
Voting Members Governing Body18VotingMembersGoverningBodyCnt
Voting Members Independent17VotingMembersIndependentCnt
Total Employee1342TotalEmployeeCnt
Total Volunteers289TotalVolunteersCnt
Total Gross UBI$4,207,653TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm$6,612NetUnrelatedBusTxblIncmAmt
PY Contributions Grants$35,533,265PYContributionsGrantsAmt
CY Contributions Grants$47,346,648CYContributionsGrantsAmt
PY Program Service Revenue$195,099,800PYProgramServiceRevenueAmt
CY Program Service Revenue$228,515,997CYProgramServiceRevenueAmt
PY Investment Income$3,894,142PYInvestmentIncomeAmt
CY Investment Income$4,323,810CYInvestmentIncomeAmt
PY Other Revenue$677,285PYOtherRevenueAmt
CY Other Revenue$833,792CYOtherRevenueAmt
PY Total Revenue$235,204,492PYTotalRevenueAmt
CY Total Revenue$281,020,247CYTotalRevenueAmt
PY Grants And Similar Paid$3,971,528PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid$4,046,177CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members$0PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members$0CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid$99,706,668PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid$112,637,915CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns$0PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns$0CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense$0CYTotalFundraisingExpenseAmt
PY Other Expenses$127,290,428PYOtherExpensesAmt
CY Other Expenses$146,956,995CYOtherExpensesAmt
PY Total Expenses$230,968,624PYTotalExpensesAmt
CY Total Expenses$263,641,087CYTotalExpensesAmt
PY Revenues Less Expenses$4,235,868PYRevenuesLessExpensesAmt
CY Revenues Less Expenses$17,379,160CYRevenuesLessExpensesAmt
Total Assets BOY$188,812,448TotalAssetsBOYAmt
Total Assets EOY$213,041,862TotalAssetsEOYAmt
Total Liabilities BOY$68,196,230TotalLiabilitiesBOYAmt
Total Liabilities EOY$75,346,695TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY$120,616,218NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY$137,695,167NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part IIIYes (X)InfoInScheduleOPartIIIInd
MissionVERSITI WISCONSIN, INC. (VERSITI) IS A BLOOD HEALTH INNOVATOR WHICH ENHANCES LIVES THROUGH DISCOVERY, DIAGNOSIS AND TREATMENT. VERSITI EXPANDS THE FRONTIERS OF PATIENT HEALTH THROUGH THE INTEGRATION OF SCIENCE, MEDICINE AND SERVICE.MissionDesc
Significant New Program Srvc0SignificantNewProgramSrvcInd
Significant Change0SignificantChangeInd
Expense$58,410,965ExpenseAmt
Grant$129,750GrantAmt
Revenue$66,310,411RevenueAmt
DescVERSITI OPERATES THE COMPREHENSIVE CENTER FOR BLEEDING DISORDERS (CCBD) UNDER A FEDERAL SUBAWARD AGREEMENT OF THE SOCIAL SECURITY ACT, PROVIDING SPECIALIZED DIAGNOSIS, TREATMENT, AND SUPPORTIVE CARE TO PATIENTS WITH INHERITED AND ACQUIRED BLEEDING AND CLOTTING DISORDERS. AS PART OF VERSITI'S MISSION TO IMPROVE PATIENT OUTCOMES, CCBD DELIVERS COMPREHENSIVE CARE THROUGH A MULTIDISCIPLINARY TEAM OF HEMATOLOGISTS, NURSES, SOCIAL WORKERS, AND SPECIALIZED STAFF. IN 2024, CCBD PROVIDED CRITICAL SERVICES TO PATIENTS WITH BLEEDING DISORDERS AND THEIR FAMILIES, INCLUDING FOR HEMOPHILIA A AND B, VON WILLEBRAND DISEASE, AND OTHER RARE COAGULATION DISORDERS. CCBD PROVIDED 17,470 SPECIALTY PHARMACY PRODUCTS IN 2024 AND CONTINUES TO BE A FEDERALLY RECOGNIZED HEMOPHILIA TREATMENT CENTER (HTC). AS A (CONTINUED IN SCHEDULE O) COVERED ENTITY UNDER THE 340B DRUG DISCOUNT PROGRAM, VERSITI ACCESSES SPECIALTY PHARMACEUTICALS AT DISCOUNTED PRICING, PASSING SAVINGS ON TO PATIENTS AND REDUCING COSTS TO THE HEALTHCARE SYSTEM WHILE ENSURING PHARMACEUTICAL NET INCOME SUPPORTS PROGRAM ACTIVITIES INCLUDING PATIENT CARE, EDUCATION, SUPPORT SERVICES, AND APPROVED RESEARCH. VERSITI PROVIDES THESE SPECIALTY PHARMACY PRODUCTS TO HOME CARE PATIENTS AND HOSPITAL SYSTEMS, IMPROVING MEDICATION ACCESS AND ADHERENCE. THE CENTER'S COMPREHENSIVE SERVICES INCLUDE FACTOR REPLACEMENT THERAPY, PROPHYLACTIC TREATMENT PROTOCOLS, GENETIC COUNSELING, AND PATIENT EDUCATION PROGRAMS DESIGNED TO HELP INDIVIDUALS WITH BLEEDING DISORDERS LIVE FULL, ACTIVE LIVES. THROUGH SPECIALIZED EXPERTISE, FEDERAL PARTNERSHIP, AND COMPASSIONATE CARE, CCBD SERVES AS A PREMIER RESOURCE FOR BLEEDING DISORDER TREATMENT, IMPROVING OUTCOMES WHILE REDUCING HEALTHCARE COSTS FOR PATIENTS WITH THESE COMPLEX CONDITIONS.Desc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

FieldValueIRS element (for citing)
Expense$47,161,515ExpenseAmt
Grant$77,971GrantAmt
Revenue$54,769,275RevenueAmt
DescVERSITI WISCONSIN RECRUITS VOLUNTEER BLOOD DONORS AND COLLECTS, PROCESSES, AND DISTRIBUTES BLOOD PRODUCTS AS PART OF ITS MISSION TO PROVIDE A SAFE AND RELIABLE BLOOD SUPPLY FOR HOSPITALS AND HEALTHCARE SYSTEMS ACROSS WISCONSIN. VERSITI'S COMPREHENSIVE BLOOD INVENTORY INCLUDES RED BLOOD CELLS, PLATELETS, PLASMA, AND SPECIALIZED PRODUCTS DESIGNED TO MEET PATIENT NEEDS. IN 2024, VERSITI WISCONSIN COLLECTED TOTAL RED BLOOD CELLS AND PLATELETS OF 152,765, SERVING 62 HOSPITALS. THE ORGANIZATION HOSTED 2,808 COMMUNITY BLOOD DRIVES, ENGAGING 56,626 VOLUNTEER DONORS WHO CONTRIBUTED TO VERSITI'S LIFESAVING MISSION. (CONTINUED IN SCHEDULE O)INNOVATION AND EMERGENCY RESPONSE: DURING 2024, VERSITI WISCONSIN PARTNERED WITH MILWAUKEE COUNTY TO LAUNCH AN INNOVATIVE EMS PREHOSPITAL WHOLE BLOOD TRANSFUSION PROGRAM FOR CRITICALLY INJURED TRAUMA PATIENTS, THE FIRST SUCH PARTNERSHIP IN WISCONSIN. COMMUNITY PARTNERSHIPS: AS A VITAL PARTNER IN PUBLIC HEALTH, VERSITI WISCONSIN PARTICIPATED IN THE #KNOWSCD SICKLE CELL DISEASE AWARENESS CAMPAIGN, THE WE GIVE BLOOD DRIVE PARTNERSHIP WITH ABBOTT AND THE BIG TEN CONFERENCE DURING THE 2024 FOOTBALL SEASON, AND THE ORGANIZATION'S VERSITI ON KING COMMUNITY CENTER CONDUCTED BLOOD TYPING EVENTS FOR 140 INDIVIDUALS, IDENTIFYING 43 POTENTIAL RO DONORS TO SUPPORT PATIENTS WITH SICKLE CELL DISEASE. INFRASTRUCTURE AND OPERATIONS: VERSITI WISCONSIN OPERATES DONOR CENTERS AND MOBILE COLLECTION UNITS THROUGHOUT THE STATE. IN 2024, THE ORGANIZATION COMPLETED 4 DONOR CENTER RENOVATIONS TO IMPROVE DONOR COMFORT, ENHANCE OPERATIONAL EFFICIENCY, AND EXPAND COLLECTION CAPACITY. THROUGH DEDICATED VOLUNTEER DONORS AND STRATEGIC COMMUNITY PARTNERSHIPS, VERSITI WISCONSIN MAINTAINS A ROBUST BLOOD SUPPLY THAT ENABLES HOSPITALS TO PROVIDE CRITICAL CARE, EMERGENCY SERVICES, AND LIFESAVING TREATMENTS TO PATIENTS THROUGHOUT THE REGION.Desc

Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp

FieldValueIRS element (for citing)
Expense$39,725,349ExpenseAmt
Grant$3,812,500GrantAmt
Revenue$0RevenueAmt
DescVERSITI RESEARCH ADVANCES SCIENTIFIC DISCOVERY AND PATIENT CARE THROUGH COMPREHENSIVE SUPPORT OF BLOOD-RELATED RESEARCH, EDUCATION, AND COMMUNITY ENGAGEMENT PROGRAMS. ROOTED IN ITS NONPROFIT MISSION, VERSITI ENABLES GROUNDBREAKING BLOOD RESEARCH WHILE FOSTERING THE NEXT GENERATION OF SCIENTISTS AND IMPROVING THE LIVES OF PATIENTS AFFLICTED BY BLOOD DISORDERS. IN 2024, VERSITI RESEARCHERS PUBLISHED 122 PEER-REVIEWED MANUSCRIPTS WITH 45 FEATURING VBRI FACULTY AS LEAD OR SENIOR AUTHORS, INCLUDING 5 PUBLICATIONS IN JOURNALS WITH IMPACT FACTORS EXCEEDING 30. 7 IN JOURNALS WITH IMPACT FACTORS BETWEEN 20 AND 30, AND 17 IN JOURNALS WITH IMPACT FACTORS BETWEEN 10 AND 20. VERSITI'S RESEARCH SPANS 5 MAJOR PROGRAMS: TRANSFUSION MEDICINE, VASCULAR BIOLOGY, AND CELLULAR THERAPY; THROMBOSIS AND (CONTINUED IN SCHEDULE O) HEMOSTASIS; STEM CELL BIOLOGY AND HEMATOPOIESIS; IMMUNOLOGY; AND TRANSLATIONAL HEMATOLOGY. VERSITI'S RESEARCH GRANT TEAMS PROCESSED APPROXIMATELY $41M IN NEW MULTI-YEAR GRANTS AND SUBMITTED 112 PROPOSALS TOTALING $140.13M IN 2024. VERSITI ALSO LEADS THROUGH COLLABORATIVE BLOOD SCIENCE INITIATIVES SUCH AS IN VENUS (VENOUS THROMBOEMBOLISM NETWORK US) AND REDS-IV-P (RECIPIENT EPIDEMIOLOGY AND DONOR EVALUATION STUDY), NATIONAL PROGRAMS ADVANCING THROMBOSIS TREATMENT AND BLOOD TRANSFUSION SAFETY. OPERATING IN AN 82,000 SQUARE-FOOT FACILITY, VERSITI IS HOME TO 213 RESEARCH STAFF, INCLUDING 35 INVESTIGATORS AND 22 RESEARCH SCIENTISTS, IN 2024. EDUCATIONAL INITIATIVES INCLUDE GRADUATE TRAINING, RESEARCH SYMPOSIA, AND COLLABORATIVE PARTNERSHIPS IN THE MILWAUKEE REGIONAL MEDICAL CENTER, SUCH AS THE MRMC HEMATOLOGY BIOREPOSITORY, WHICH PROVIDES ANNOTATED BIOLOGICAL SAMPLES FOR BIOMARKER DISCOVERY FOR CLINICAL PARTNERS THROUGHOUT CAMPUS.Desc

Prog Srvc Accom Acty Other ProgSrvcAccomActyOtherGrp

FieldValueIRS element (for citing)
Expense$83,154,607ExpenseAmt
Grant$25,956GrantAmt
Revenue$107,438,365RevenueAmt
DescMSI:THE VERSITI MEDICAL SERVICES INSTITUTE (MSI) ADVANCES PATIENT CARE THROUGH SPECIALIZED TREATMENT AND TRANSLATIONAL RESEARCH THAT BRIDGES CLINICAL MEDICINE AND LABORATORY SCIENCE, FOSTERING COLLABORATION BETWEEN PHYSICIAN-SCIENTISTS AND BASIC RESEARCHERS TO ACCELERATE MEDICAL DISCOVERIES. ESTABLISHED IN 2009 AND SUPPORTED BY VERSITI AND THE VERSITI BLOOD RESEARCH INSTITUTE FOUNDATION, MSI ENABLES PHYSICIANS TO DEDICATE PROTECTED TIME TO CLINICAL RESEARCH WHILE MAINTAINING PATIENT CARE RESPONSIBILITIES. IN 2024, VERSITI PHYSICIAN-SCIENTISTS PERFORMED 3,686 THERAPEUTIC PROCEDURES. AS PART OF VERSITI'S MISSION TO ADVANCE EVIDENCE-BASED MEDICINE, MSI OPERATES THE CLINICAL TRIALS & RESEARCH OFFICE (CTRO) TO CONDUCT FDA-REGULATED CLINICAL STUDIES IN SPECIALIZED AREAS INCLUDING ALLOIMMUNE PLATELET DISORDERS, TRANSFUSION-INDUCED ACUTE LUNG INJURY, AND DRUG-INDUCED BLOOD DISORDERS. THROUGH MENTORSHIP, PROTECTED RESEARCH TIME, AND COLLABORATIVE INFRASTRUCTURE, MSI PROVIDES DEEP CLINICAL EXPERTISE AND TRANSFORMS CLINICAL QUESTIONS INTO SCIENTIFIC DISCOVERIES THAT BENEFIT PATIENTS WITH BLOOD DISORDERS NATIONWIDE.DONOR TESTING:THE VERSITI DONOR TESTING LABORATORY (DTL) PROVIDES INFECTIOUS DISEASE TESTING TO DETERMINE DONOR SUITABILITY AND PRODUCT SAFETY FOR ORGANS, TISSUES, HEMATOPOIETIC STEM CELLS, AND CORD BLOOD. THE DTL OFFERS NUCLEIC ACID TESTING, ANTIBODY SCREENING, AND CONFIRMATORY TESTING FOR MANY DIFFERENT DISEASE STATES. AS PART OF VERSITI'S MISSION TO MAINTAIN THE SAFEST POSSIBLE BLOOD SUPPLY, DONOR TESTING OPERATIONS CONDUCT MANDATORY SCREENING FOR TRANSFUSION-TRANSMISSIBLE INFECTIONS AS REQUIRED BY FDA REGULATIONS. THE DTL UTILIZES STATE-OF-THE-ART NUCLEIC ACID TESTING (NAT) TECHNOLOGY AND SEROLOGICAL METHODS TO DETECT INFECTIOUS AGENTS. VERSITI'S DTL SUPPORTS BLOOD COLLECTION ACTIVITIES ACROSS VERSITI'S ENTIRE GEOGRAPHIC FOOTPRINT WHILE MAINTAINING RIGOROUS QUALITY STANDARDS AND REGULATORY COMPLIANCE. VERSITI'S DONOR TESTING SERVICES STRENGTHEN THE NATIONAL BLOOD SUPPLY INFRASTRUCTURE. BY ENSURING COMPREHENSIVE DONOR SCREENING, VERSITI PROTECTS PATIENTS WHO DEPEND ON SAFE BLOOD TRANSFUSIONS, STRENGTHENS THE NATIONAL BLOOD SUPPLY, AND SUPPORTS THE BROADER PUBLIC HEALTH MISSION OF MAINTAINING CONFIDENCE IN A HIGH-QUALITY BLOOD SUPPLY.DIAGNOSTIC LABS:VERSITI SERVES PATIENTS, PHYSICIANS, AND HOSPITALS BY PROVIDING COMPREHENSIVE CLINICAL DIAGNOSTIC TESTING SERVICES THAT SUPPORT ACCURATE DIAGNOSIS, TREATMENT MONITORING, AND PATIENT CARE ACROSS MULTIPLE MEDICAL SPECIALTIES. AS PART OF VERSITI'S MISSION TO ADVANCE HEALTHCARE THROUGH LABORATORY EXCELLENCE, THE DIAGNOSTIC LABORATORIES DELIVER SPECIALIZED TESTING SERVICES INCLUDING HEMATOLOGY, COAGULATION, IMMUNOHEMATOLOGY, INFECTIOUS DISEASE, MOLECULAR DIAGNOSTICS, FLOW CYTOMETRY, AND REFERENCE LABORATORY SERVICES. DURING 2024, VERSITI CONDUCTED 148,545 DIAGNOSTIC TESTING SERVICES FOR HOSPITALS, PHYSICIAN OFFICES, AND REFERENCE LABORATORIES. VERSITI'S DIAGNOSTIC LABORATORIES MAINTAIN STATE-OF-THE-ART INSTRUMENTATION AND RIGOROUS QUALITY ASSURANCE PROGRAMS TO ENSURE ACCURATE, TIMELY RESULTS THAT GUIDE CLINICAL DECISION-MAKING AND IMPROVE PATIENT OUTCOMES. THE LABORATORIES PROVIDE SPECIALIZED EXPERTISE IN BLOOD-RELATED DISORDERS, OFFERING ADVANCED TESTING CAPABILITIES INCLUDING PLATELET FUNCTION ANALYSIS, COAGULATION STUDIES, RED BLOOD CELL ANTIGEN TYPING, AND COMPLEX IMMUNOHEMATOLOGY WORKUPS THAT CONFIRM AND ENSURE TRANSFUSION SAFETY. VERSITI'S DIAGNOSTIC LABORATORIES SERVE AS A VITAL HEALTHCARE INFRASTRUCTURE RESOURCE, PROVIDING 24/7 TESTING SUPPORT FOR EMERGENCY DEPARTMENTS AND CRITICAL CARE UNITS. THROUGH COMPREHENSIVE DIAGNOSTIC TESTING SERVICES, ADVANCED LABORATORY EXPERTISE, AND COMMITMENT TO QUALITY, VERSITI'S DIAGNOSTIC LABORATORIES STRENGTHEN THE HEALTHCARE SYSTEM BY ENABLING ACCURATE DIAGNOSIS AND OPTIMAL PATIENT CARE ACROSS THE STATE.ORGAN AND TISSUE:VERSITI ORGAN AND TISSUE OPERATES AS SOUTHEASTERN WISCONSIN'S FEDERALLY DESIGNATED ORGAN PROCUREMENT ORGANIZATION, COORDINATING ORGAN AND TISSUE DONATION TO SAVE AND HEAL LIVES THROUGHOUT THE STATE. ROOTED IN VERSITI'S MISSION TO ADVANCE PUBLIC HEALTH, THE ORGANIZATION FACILITATES THE GENEROUS GIFT OF DONATION BY WORKING WITH DONOR FAMILIES, HOSPITALS, AND TRANSPLANT CENTERS TO ENSURE ORGANS AND TISSUES REACH PATIENTS IN NEED. IN 2024, VERSITI ORGAN AND TISSUE COORDINATED 394 ORGAN TRANSPLANTS FROM 606 MUSCULOSKELETAL DONORS. THE ORGANIZATION PROVIDES 24/7 COORDINATION SERVICES, FAMILY SUPPORT, AND CLINICAL EXPERTISE THROUGHOUT THE DONATION PROCESS. VERSITI'S DONATION COORDINATORS AND CLINICAL STAFF WORK ALONGSIDE HOSPITAL TEAMS TO IDENTIFY POTENTIAL DONORS, SUPPORT GRIEVING FAMILIES, AND ENSURE OPTIMAL ORGAN AND TISSUE RECOVERY. THROUGH COMMUNITY EDUCATION PROGRAMS LIKE DONATE LIFE MONTH IN APRIL, VERSITI PROMOTES DONATION AWARENESS AND SUPPORTS WISCONSIN FAMILIES WHO CHOOSE THE HEALING PATH OF DONATION. BY FACILITATING ORGAN AND TISSUE DONATION, VERSITI ORGAN AND TISSUE TRANSFORMS TRAGEDY INTO HOPE, ENABLING ONE DONOR TO SAVE UP TO EIGHT LIVES THROUGH ORGAN DONATION AND HEAL DOZENS MORE THROUGH TISSUE DONATION.VCTS:VERSITI CLINICAL TRIALS SERVICES (VCTS) PROVIDES COMPREHENSIVE CLINICAL RESEARCH SERVICES TO PHARMACEUTICAL SPONSORS, BIOTECHNOLOGY COMPANIES, AND ACADEMIC INSTITUTIONS CONDUCTING CLINICAL STUDIES IN HEMATOLOGY, TRANSFUSION MEDICINE, ONCOLOGY, IMMUNOLOGY, CELL AND GENE THERAPY, AND ORPHAN AND RARE DISEASES. AS PART OF VERSITI'S MISSION TO ADVANCE MEDICAL SCIENCE, VCTS OFFERS SPECIALIZED LABORATORY SERVICES, INSTITUTIONAL REVIEW BOARD (IRB) OVERSIGHT, BIOSPECIMEN COLLECTION AND MANAGEMENT, PROJECT MANAGEMENT, AND REGULATORY SUPPORT TO ENSURE SAFE AND COMPLIANT STUDIES. VCTS LEVERAGES VERSITI'S UNIQUE EXPERTISE IN BLOOD SCIENCE AND LABORATORY DIAGNOSTICS TO SUPPORT COMPLEX TRIALS REQUIRING SPECIALIZED TESTING CAPABILITIES. THE PROGRAM MAINTAINS RIGOROUS QUALITY STANDARDS AND REGULATORY COMPLIANCE WHILE PROVIDING INNOVATIVE SOLUTIONS FOR COMPLEX CLINICAL RESEARCH CHALLENGES. THROUGH EXPERT CLINICAL RESEARCH SERVICES, VERSITI CLINICAL TRIALS ACCELERATE THE DEVELOPMENT OF NEW TREATMENTS FOR BLOOD DISORDERS AND SUPPORT THE ADVANCEMENT OF EVIDENCE-BASED MEDICINE IN HEMATOLOGY AND TRANSFUSION MEDICINE.Desc
FieldValueIRS element (for citing)
Total Other Prog Srvc Expense$83,154,607TotalOtherProgSrvcExpenseAmt
Total Other Prog Srvc Grant$25,956TotalOtherProgSrvcGrantAmt
Total Other Prog Srvc Revenue$107,438,365TotalOtherProgSrvcRevenueAmt
Total Program Service Expenses$228,452,436TotalProgramServiceExpensesAmt
Described In Section501c3Yes (1)DescribedInSection501c3Ind
Schedule B RequiredYes (1)ScheduleBRequiredInd
Political Campaign Acty0PoliticalCampaignActyInd
Lobbying ActivitiesYes (1)LobbyingActivitiesInd
Subject To Proxy Tax0SubjectToProxyTaxInd
Donor Advised Fund0DonorAdvisedFundInd
Conservation Easements0ConservationEasementsInd
Collections Of Art0CollectionsOfArtInd
Credit Counseling0CreditCounselingInd
Donor Rstr Or Quasi EndowmentsYes (1)DonorRstrOrQuasiEndowmentsInd
Report Land Building EquipmentYes (1)ReportLandBuildingEquipmentInd
Report Investments Other SecYes (1)ReportInvestmentsOtherSecInd
Report Program Related Invst0ReportProgramRelatedInvstInd
Report Other Assets0ReportOtherAssetsInd
Report Other LiabilitiesYes (1)ReportOtherLiabilitiesInd
Include FIN48 FootnoteYes (1)IncludeFIN48FootnoteInd
Independent Audit Fincl Stmt0IndependentAuditFinclStmtInd
Consolidated Audit Fincl StmtYes (1)ConsolidatedAuditFinclStmtInd
School Operating0SchoolOperatingInd
Foreign Office0ForeignOfficeInd
Foreign Activities0ForeignActivitiesInd
More Than5000 K To Org0MoreThan5000KToOrgInd
More Than5000 K To Individuals0MoreThan5000KToIndividualsInd
Professional Fundraising0ProfessionalFundraisingInd
Fundraising ActivitiesYes (1)FundraisingActivitiesInd
Gaming Activities0GamingActivitiesInd
Operate Hospital0OperateHospitalInd
Grants To OrganizationsYes (1)GrantsToOrganizationsInd
Grants To IndividualsYes (1)GrantsToIndividualsInd
Schedule J RequiredYes (1)ScheduleJRequiredInd
Tax Exempt Bonds0TaxExemptBondsInd
Engaged In Excess Benefit Trans0EngagedInExcessBenefitTransInd
PY Excess Benefit Trans0PYExcessBenefitTransInd
Loan Outstanding0LoanOutstandingInd
Grant To Related Person0GrantToRelatedPersonInd
Business Rln With Org Mem0BusinessRlnWithOrgMemInd
Business Rln With Fam Mem0BusinessRlnWithFamMemInd
Business Rln With35 Ctrl Ent0BusinessRlnWith35CtrlEntInd
Deductible Non Cash Contri0DeductibleNonCashContriInd
Deductible Art Contribution0DeductibleArtContributionInd
Terminate Operations0TerminateOperationsInd
Partial Liquidation0PartialLiquidationInd
Disregarded EntityYes (1)DisregardedEntityInd
Related EntityYes (1)RelatedEntityInd
Related Organization Ctrl EntYes (1)RelatedOrganizationCtrlEntInd
Transaction With Control EntYes (1)TransactionWithControlEntInd
Trnsfr Exmpt Non Chrtbl Rltd Org0TrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted Prtshp0ActivitiesConductedPrtshpInd
Schedule O RequiredYes (1)ScheduleORequiredInd
IRP Document0IRPDocumentCnt
IRP Document W2 G0IRPDocumentW2GCnt
Employee1342EmployeeCnt
Employment Tax Returns FiledYes (1)EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over LimitYes (1)UnrelatedBusIncmOverLimitInd
Form990 T FiledYes (1)Form990TFiledInd
Foreign Financial Account0ForeignFinancialAccountInd
Prohibited Tax Shelter Trans0ProhibitedTaxShelterTransInd
Taxable Party Notification0TaxablePartyNotificationInd
Nondeductible Contributions0NondeductibleContributionsInd
Quid Pro Quo Contributions0QuidProQuoContributionsInd
Form8282 Property Disposed Of0Form8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft Cntrct0RcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft Cntrct0PayPremiumsPrsnlBnftCntrctInd
Indoor Tanning Services0IndoorTanningServicesInd
Subj To Tax Rmnrtn Ex Prcht PymtYes (1)SubjToTaxRmnrtnExPrchtPymtInd
Subject To Excs Tax Net Invst Inc0SubjectToExcsTaxNetInvstIncInd
Info In Schedule O Part VIYes (X)InfoInScheduleOPartVIInd
Governing Body Voting Members18GoverningBodyVotingMembersCnt
Independent Voting Member17IndependentVotingMemberCnt
Family Or Business Rln0FamilyOrBusinessRlnInd
Delegation Of Mgmt Duties0DelegationOfMgmtDutiesInd
Change To Org Documents0ChangeToOrgDocumentsInd
Material Diversion Or Misuse0MaterialDiversionOrMisuseInd
Members Or StockholdersYes (1)MembersOrStockholdersInd
Election Of Board MembersYes (1)ElectionOfBoardMembersInd
Decisions Subject To ApprovaYes (1)DecisionsSubjectToApprovaInd
Minutes Of Governing BodyYes (1)MinutesOfGoverningBodyInd
Minutes Of CommitteesYes (1)MinutesOfCommitteesInd
Officer Mailing Address0OfficerMailingAddressInd
Local Chapters0LocalChaptersInd
Form990 Provided To Gvrn BodyYes (1)Form990ProvidedToGvrnBodyInd
Conflict Of Interest PolicyYes (1)ConflictOfInterestPolicyInd
Annual Disclosure Covered PrsnYes (1)AnnualDisclosureCoveredPrsnInd
Regular Monitoring EnfrcYes (1)RegularMonitoringEnfrcInd
Whistleblower PolicyYes (1)WhistleblowerPolicyInd
Document Retention PolicyYes (1)DocumentRetentionPolicyInd
Compensation Process CEOYes (1)CompensationProcessCEOInd
Compensation Process OtherYes (1)CompensationProcessOtherInd
Investment In Joint Venture0InvestmentInJointVentureInd
States Where Copy Of Return Is FldWIStatesWhereCopyOfReturnIsFldCd
Upon RequestYes (X)UponRequestInd
OtherYes (X)OtherInd

Books In Care Of Detail BooksInCareOfDetail

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1DAWN HENSEBusinessNameLine1Txt
FieldValueIRS element (for citing)
Phone4149335000PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line1638 N 18TH STAddressLine1Txt
CityMILWAUKEECityNm
State AbbreviationWIStateAbbreviationCd
ZIP532332121ZIPCd
FieldValueIRS element (for citing)
Info In Schedule O Part VIIYes (X)InfoInScheduleOPartVIIInd

Form990 Part VII Section A Form990PartVIISectionAGrp (37 entries)

TitleTitleTxtAverage Hours Per WeekAverageHoursPerWeekRtAverage Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRtIndividual Trustee Or DirectorIndividualTrusteeOrDirectorIndOfficerOfficerIndReportable Comp From OrgReportableCompFromOrgAmtReportable Comp From Rltd OrgReportableCompFromRltdOrgAmtOther CompensationOtherCompensationAmtHighest Compensated EmployeeHighestCompensatedEmployeeInd
CHRIS MISKEL
PRESIDENT & CEO23.0032.00Yes (X)Yes (X)$713,940$908,656$57,669
FRED GEILFUSS
CHAIR1.005.00Yes (X)Yes (X)$0$0$0
L ALAN WHALEY
VICE CHAIR1.004.00Yes (X)Yes (X)$0$0$0
COREEN DICUS-JOHNSON JD
SECRETARY1.004.00Yes (X)Yes (X)$0$0$0
RON MILLER
TREASURER1.004.00Yes (X)Yes (X)$0$0$0
NICHOLAS BAUER
BOARD MEMBER1.004.00Yes (X)$0$0$0
DAVID GINSBURG MD
BOARD MEMBER1.004.00Yes (X)$0$0$0
CECELIA GORE
BOARD MEMBER1.004.00Yes (X)$0$0$0
GAIL HANSON
BOARD MEMBER1.004.00Yes (X)$0$0$0
THOMAS HAUSKE JR
BOARD MEMBER1.004.00Yes (X)$0$0$0
SHERRY HUSA
BOARD MEMBER1.004.00Yes (X)$0$0$0
DALE KENT
BOARD MEMBER1.004.00Yes (X)$0$0$0
ROBERT H MANEGOLD
BOARD MEMBER1.005.00Yes (X)$0$0$0
JEFFREY S MCDONALD
BOARD MEMBER1.004.00Yes (X)$0$0$0
MAGGEY OPLINGER
BOARD MEMBER1.004.00Yes (X)$0$0$0
JOHN PERRAS
BOARD MEMBER1.004.00Yes (X)$0$0$0
KATHY THORNTON-BIAS
BOARD MEMBER - THRU 6/241.004.00Yes (X)$0$0$0
GREG WESLEY
BOARD MEMBER1.004.00Yes (X)$0$0$0
PETER ZIEGLER
BOARD MEMBER1.004.00Yes (X)$0$0$0
MATTHEW ANDERSON MD
EVP & CHIEF MED. OFF. - AS OF 7/2450.005.00Yes (X)$471,868$0$65,850
BRIAN BAUTISTA
EVP & CHIEF OPERATING OFFICER24.0031.00Yes (X)$357,615$455,150$53,592
LYNNE BRIGGS
VP & CHIEF INFORMATION OFFICER24.0031.00Yes (X)$212,020$269,846$52,622
BARBARA BRYANT
EVP & CHIEF MED. OFF. - THRU 8/2450.005.00Yes (X)$447,822$0$25,848
MICHAEL DEININGER MD
EVP & CHIEF SCIENTIFIC OFFICER48.007.00Yes (X)$637,080$33,530$39,231
JESSICA DROUILLARD
VP & CHIEF QUALITY OFFICER24.0031.00Yes (X)$121,455$154,582$18,905
GITESH DUBAL
EVP & CHIEF MKTG. OFF. - THRU 4/2424.0031.00Yes (X)$179,108$227,952$23,781
GRETCHEN JAMESON
EVP & CHIEF MKTG. OFF. - AS OF 4/2424.0031.00Yes (X)$96,983$123,432$15,013
BRADLEY PIETZ
EVP & CHIEF LABORATORY OFFICER24.0031.00Yes (X)$264,400$336,515$65,430
BART REUTER
EVP & GENERAL COUNSEL23.0032.00Yes (X)$379,102$482,498$66,046
DEREK TYUS
EVP & CHIEF FINANCIAL OFF. - AS 3/2423.0032.00Yes (X)$199,013$253,291$48,353
ANTHONY WATKINS
EVP&CFO-THRU 3/24;BUS DEV-AS OF 3/2423.0032.00Yes (X)$329,433$419,278$29,876
JAMES WEIDNER
EVP & CHIEF HR OFFICER24.0031.00Yes (X)$251,504$320,098$56,792
KATHLEEN PUCA
SR MEDICAL DIRECTOR55.000.00$442,557$0$55,500Yes (X)
KARIN HOFFMEISTER
DEPUTY DIRECTOR VBRI55.000.00$411,046$0$49,328Yes (X)
CHRISTIAN J KASTRUP PHD
SR INVESTIGATOR55.000.00$399,219$0$61,882Yes (X)
LYNN M MALEC MD
SENIOR MEDICAL DIRECTOR55.000.00$384,247$0$34,890Yes (X)
LISA BAUMANN KREUZIGER
SENIOR MEDICAL DIRECTOR55.000.00$394,936$0$40,578Yes (X)
FieldValueIRS element (for citing)
Total Reportable Comp From Org$6,693,348TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org$3,984,828TotReportableCompRltdOrgAmt
Total Other Compensation$861,186TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K211IndivRcvdGreaterThan100KCnt
Former Ofcr Employees Listed0FormerOfcrEmployeesListedInd
Total Comp Greater Than150 KYes (1)TotalCompGreaterThan150KInd
Compensation From Other Srcs0CompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp (5 entries)

Address Line1ContractorAddress/USAddress/AddressLine1TxtCityContractorAddress/USAddress/CityNmState AbbreviationContractorAddress/USAddress/StateAbbreviationCdZIPContractorAddress/USAddress/ZIPCdServicesServicesDescCompensationCompensationAmt
MORTENSON CONSTRUCTION
115 S 84TH STREET STE 400MILWAUKEEWI53214CONTRACTOR$6,364,631
HGA
PO BOX 86MINNEAPOLISMN55486BUILDING DESIGN FIRM$3,359,610
MEDICAL COLLEGE OF WISCONSIN INC
8701 WATERTOWN PLANK RDMILWAUKEEWI53226RESEARCH SERVICES$2,878,711
HEALTH RESEARCH INC
PO BOX 2966BUFFALONY14240RESEARCH SERVICES$790,499
CERNER CORPORATION
2800 ROCKCREEK PARKWAYKANSAS CITYMO64117SOFTWARE SUPPORT$785,249
FieldValueIRS element (for citing)
Cntrct Rcvd Greater Than100 K35CntrctRcvdGreaterThan100KCnt
Federated Campaigns$1,170FederatedCampaignsAmt
Fundraising$65,534FundraisingAmt
Related Organizations$10,774,042RelatedOrganizationsAmt
Government Grants$32,588,850GovernmentGrantsAmt
All Other Contributions$3,917,052AllOtherContributionsAmt
Total Contributions$47,346,648TotalContributionsAmt

Program Service Revenue ProgramServiceRevenueGrp (5 entries)

DescDescBusinessBusinessCdTotal Revenue ColumnTotalRevenueColumnAmtRelated Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmtUnrelated Business RevenueUnrelatedBusinessRevenueAmt
PHARMACY621500$66,310,411$66,310,411
BLOOD SERVICES621991$54,769,275$54,769,275
DIAGNOSTIC LABS621500$51,114,322$51,114,322
ORGAN & TISSUE621991$26,103,956$26,103,956
BIOMATERIALS & TRIALS621500$17,724,701$13,745,824$3,978,877

Total Oth Program Service Rev TotalOthProgramServiceRevGrp

FieldValueIRS element (for citing)
Total Revenue Column$12,493,332TotalRevenueColumnAmt
Related Or Exempt Func Income$12,493,332RelatedOrExemptFuncIncomeAmt
FieldValueIRS element (for citing)
Total Program Service Revenue$228,515,997TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

FieldValueIRS element (for citing)
Total Revenue Column$3,849,579TotalRevenueColumnAmt
Exclusion$3,849,579ExclusionAmt

Gross Rents GrossRentsGrp

FieldValueIRS element (for citing)
Real$4,483RealAmt

Less Rental Expenses LessRentalExpensesGrp

FieldValueIRS element (for citing)
Real$12,144RealAmt

Rental Income Or Loss RentalIncomeOrLossGrp

FieldValueIRS element (for citing)
Real-$7,661RealAmt

Net Rental Income Or Loss NetRentalIncomeOrLossGrp

FieldValueIRS element (for citing)
Total Revenue Column-$7,661TotalRevenueColumnAmt
Exclusion-$7,661ExclusionAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

FieldValueIRS element (for citing)
Securities$22,907,473SecuritiesAmt
Other$63,159OtherAmt

Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp

FieldValueIRS element (for citing)
Securities$22,470,012SecuritiesAmt
Other$26,389OtherAmt

Gain Or Loss GainOrLossGrp

FieldValueIRS element (for citing)
Securities$437,461SecuritiesAmt
Other$36,770OtherAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

FieldValueIRS element (for citing)
Total Revenue Column$474,231TotalRevenueColumnAmt
Exclusion$474,231ExclusionAmt
FieldValueIRS element (for citing)
Fundraising Gross Income$26,200FundraisingGrossIncomeAmt
Contri Rpt Fundraising Event$65,534ContriRptFundraisingEventAmt
Fundraising Direct Expenses$37,690FundraisingDirectExpensesAmt

Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp

FieldValueIRS element (for citing)
Total Revenue Column-$11,490TotalRevenueColumnAmt
Exclusion-$11,490ExclusionAmt

Other Revenue Misc OtherRevenueMiscGrp (3 entries)

DescDescBusinessBusinessCdTotal Revenue ColumnTotalRevenueColumnAmtExclusionExclusionAmtUnrelated Business RevenueUnrelatedBusinessRevenueAmt
AFFILIATE SERVICE FEES900099$551,381$551,381
SHARED SERVICE FEE900099$228,776$228,776
ACQUIRED CASH RECEIPTS900099$66,667$66,667

Miscellaneous Revenue MiscellaneousRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$6,119TotalRevenueColumnAmt
Related Or Exempt Func Income$2,054RelatedOrExemptFuncIncomeAmt
Exclusion$4,065ExclusionAmt
FieldValueIRS element (for citing)
Other Revenue Total$852,943OtherRevenueTotalAmt

Total Revenue TotalRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$281,020,247TotalRevenueColumnAmt
Related Or Exempt Func Income$224,539,174RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$4,207,653UnrelatedBusinessRevenueAmt
Exclusion$4,926,772ExclusionAmt
FieldValueIRS element (for citing)
Info In Schedule O Part IXYes (X)InfoInScheduleOPartIXInd

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

FieldValueIRS element (for citing)
Total$4,042,177TotalAmt
Program Services$4,042,177ProgramServicesAmt

Grants To Domestic Individuals GrantsToDomesticIndividualsGrp

FieldValueIRS element (for citing)
Total$4,000TotalAmt
Program Services$4,000ProgramServicesAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

FieldValueIRS element (for citing)
Total$4,364,390TotalAmt
Program Services$2,360,124ProgramServicesAmt
Management And General$2,004,266ManagementAndGeneralAmt

Comp Disqual Persons CompDisqualPersonsGrp

FieldValueIRS element (for citing)
Total$102,960TotalAmt
Management And General$102,960ManagementAndGeneralAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

FieldValueIRS element (for citing)
Total$84,138,998TotalAmt
Program Services$72,439,819ProgramServicesAmt
Management And General$11,699,179ManagementAndGeneralAmt

Pension Plan Contributions PensionPlanContributionsGrp

FieldValueIRS element (for citing)
Total$4,236,051TotalAmt
Program Services$3,596,963ProgramServicesAmt
Management And General$639,088ManagementAndGeneralAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

FieldValueIRS element (for citing)
Total$13,961,252TotalAmt
Program Services$11,754,277ProgramServicesAmt
Management And General$2,206,975ManagementAndGeneralAmt

Payroll Taxes PayrollTaxesGrp

FieldValueIRS element (for citing)
Total$5,834,264TotalAmt
Program Services$4,905,023ProgramServicesAmt
Management And General$929,241ManagementAndGeneralAmt

Fees For Services Legal FeesForServicesLegalGrp

FieldValueIRS element (for citing)
Total$181,659TotalAmt
Program Services$61,385ProgramServicesAmt
Management And General$120,274ManagementAndGeneralAmt

Fees For Services Accounting FeesForServicesAccountingGrp

FieldValueIRS element (for citing)
Total$83,827TotalAmt
Program Services$83,827ProgramServicesAmt

Fees For Services Lobbying FeesForServicesLobbyingGrp

FieldValueIRS element (for citing)
Total$66,375TotalAmt
Management And General$66,375ManagementAndGeneralAmt

Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp

FieldValueIRS element (for citing)
Total$5,895TotalAmt
Management And General$5,895ManagementAndGeneralAmt

Fees For Services Other FeesForServicesOtherGrp

FieldValueIRS element (for citing)
Total$27,035,483TotalAmt
Program Services$26,117,290ProgramServicesAmt
Management And General$918,193ManagementAndGeneralAmt

Advertising AdvertisingGrp

FieldValueIRS element (for citing)
Total$876,369TotalAmt
Program Services$475,391ProgramServicesAmt
Management And General$400,978ManagementAndGeneralAmt

Office Expenses OfficeExpensesGrp

FieldValueIRS element (for citing)
Total$493,537TotalAmt
Program Services$473,267ProgramServicesAmt
Management And General$20,270ManagementAndGeneralAmt

Information Technology InformationTechnologyGrp

FieldValueIRS element (for citing)
Total$2,661,427TotalAmt
Program Services$2,346,892ProgramServicesAmt
Management And General$314,535ManagementAndGeneralAmt

Royalties RoyaltiesGrp

FieldValueIRS element (for citing)
Total$15,727TotalAmt
Program Services$15,727ProgramServicesAmt

Occupancy OccupancyGrp

FieldValueIRS element (for citing)
Total$6,611,048TotalAmt
Program Services$4,378,606ProgramServicesAmt
Management And General$2,232,442ManagementAndGeneralAmt

Travel TravelGrp

FieldValueIRS element (for citing)
Total$3,119,840TotalAmt
Program Services$2,594,302ProgramServicesAmt
Management And General$525,538ManagementAndGeneralAmt

Conferences Meetings ConferencesMeetingsGrp

FieldValueIRS element (for citing)
Total$547,720TotalAmt
Program Services$473,533ProgramServicesAmt
Management And General$74,187ManagementAndGeneralAmt

Interest InterestGrp

FieldValueIRS element (for citing)
Total$87,941TotalAmt
Program Services$58,178ProgramServicesAmt
Management And General$29,763ManagementAndGeneralAmt

Depreciation Depletion DepreciationDepletionGrp

FieldValueIRS element (for citing)
Total$6,659,756TotalAmt
Program Services$5,063,766ProgramServicesAmt
Management And General$1,595,990ManagementAndGeneralAmt

Insurance InsuranceGrp

FieldValueIRS element (for citing)
Total$99,513TotalAmt
Program Services$99,513ProgramServicesAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDescTotalTotalAmtProgram ServicesProgramServicesAmtManagement And GeneralManagementAndGeneralAmt
COST OF IMPORTED PROD$54,780,339$54,780,339
MEDICAL LAB SUPPLIES$24,878,103$24,878,103
VERSITI SERVICES ALLOC$14,610,805$4,344,313$10,266,492
EQUIPMENT LEASE/MAINT$3,621,223$3,076,794$544,429

All Other Expenses AllOtherExpensesGrp

FieldValueIRS element (for citing)
Total$520,408TotalAmt
Program Services$28,827ProgramServicesAmt
Management And General$491,581ManagementAndGeneralAmt

Total Functional Expenses TotalFunctionalExpensesGrp

FieldValueIRS element (for citing)
Total$263,641,087TotalAmt
Program Services$228,452,436ProgramServicesAmt
Management And General$35,188,651ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

FieldValueIRS element (for citing)
BOY$4,778,539BOYAmt
EOY$4,421,429EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

FieldValueIRS element (for citing)
BOY$2,528,124BOYAmt
EOY$12,547,670EOYAmt

Accounts Receivable AccountsReceivableGrp

FieldValueIRS element (for citing)
BOY$38,464,994BOYAmt
EOY$42,233,253EOYAmt

Receivables From Officers Etc ReceivablesFromOfficersEtcGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Rcvbl From Disqualified Prsn RcvblFromDisqualifiedPrsnGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Oth Notes Loans Receivable Net OthNotesLoansReceivableNetGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Inventories For Sale Or Use InventoriesForSaleOrUseGrp

FieldValueIRS element (for citing)
BOY$11,173,130BOYAmt
EOY$12,095,944EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

FieldValueIRS element (for citing)
BOY$1,181,467BOYAmt
EOY$980,278EOYAmt
FieldValueIRS element (for citing)
Land Bldg Equip Cost Or Other Bss$140,723,165LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec$89,691,845LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

FieldValueIRS element (for citing)
BOY$40,808,629BOYAmt
EOY$51,031,320EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

FieldValueIRS element (for citing)
BOY$44,952,503BOYAmt
EOY$46,603,137EOYAmt

Investments Other Securities InvestmentsOtherSecuritiesGrp

FieldValueIRS element (for citing)
BOY$17,143,314BOYAmt
EOY$16,217,402EOYAmt

Investments Program Related InvestmentsProgramRelatedGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Intangible Assets IntangibleAssetsGrp

FieldValueIRS element (for citing)
BOY$25,991,764BOYAmt
EOY$24,989,420EOYAmt

Other Assets Total OtherAssetsTotalGrp

FieldValueIRS element (for citing)
BOY$1,789,984BOYAmt
EOY$1,922,009EOYAmt

Total Assets TotalAssetsGrp

FieldValueIRS element (for citing)
BOY$188,812,448BOYAmt
EOY$213,041,862EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

FieldValueIRS element (for citing)
BOY$49,314,606BOYAmt
EOY$56,506,442EOYAmt

Grants Payable GrantsPayableGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Deferred Revenue DeferredRevenueGrp

FieldValueIRS element (for citing)
BOY$3,602,994BOYAmt
EOY$2,125,503EOYAmt

Tax Exempt Bond Liabilities TaxExemptBondLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Escrow Account Liability EscrowAccountLiabilityGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Loans From Officers Directors LoansFromOfficersDirectorsGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Mortg Notes Pybl Scrd Invst Prop MortgNotesPyblScrdInvstPropGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Unsecured Notes Loans Payable UnsecuredNotesLoansPayableGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Other Liabilities OtherLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$15,278,630BOYAmt
EOY$16,714,750EOYAmt

Total Liabilities TotalLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$68,196,230BOYAmt
EOY$75,346,695EOYAmt
FieldValueIRS element (for citing)
Organization Follows FASB117Yes (X)OrganizationFollowsFASB117Ind

No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp

FieldValueIRS element (for citing)
BOY$120,616,218BOYAmt
EOY$125,994,810EOYAmt

Donor Restriction Net Assets DonorRestrictionNetAssetsGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$11,700,357EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$120,616,218BOYAmt
EOY$137,695,167EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$188,812,448BOYAmt
EOY$213,041,862EOYAmt
FieldValueIRS element (for citing)
Info In Schedule O Part XIYes (X)InfoInScheduleOPartXIInd
Reconcilation Revenue Expnss$17,379,160ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst$999,785NetUnrlzdGainsLossesInvstAmt
Other Changes In Net Assets-$1,299,996OtherChangesInNetAssetsAmt
Method Of Accounting AccrualYes (X)MethodOfAccountingAccrualInd
Accountant Compile Or Review0AccountantCompileOrReviewInd
FS AuditedYes (1)FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

FieldValueIRS element (for citing)
Consolidated Basis Fincl StmtYes (X)ConsolidatedBasisFinclStmtInd
FieldValueIRS element (for citing)
Audit CommitteeYes (1)AuditCommitteeInd
Federal Grant Audit RequiredYes (1)FederalGrantAuditRequiredInd
Federal Grant Audit PerformedYes (1)FederalGrantAuditPerformedInd

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Public Organization170Yes (X)PublicOrganization170Ind

Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$26,647,932CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$26,132,948CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$31,822,899CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$35,533,265CurrentTaxYearMinus1YearAmt
Current Tax Year$47,346,648CurrentTaxYearAmt
Total$167,483,692TotalAmt

Total Calendar Year170 TotalCalendarYear170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$26,647,932CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$26,132,948CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$31,822,899CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$35,533,265CurrentTaxYearMinus1YearAmt
Current Tax Year$47,346,648CurrentTaxYearAmt
Total$167,483,692TotalAmt
FieldValueIRS element (for citing)
Substantial Contributors Tot$40,835,796SubstantialContributorsTotAmt
Public Support Total170$126,647,896PublicSupportTotal170Amt

Gross Investment Income170 GrossInvestmentIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$1,862,957CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$1,963,086CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$1,514,098CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$3,484,842CurrentTaxYearMinus1YearAmt
Current Tax Year$3,854,062CurrentTaxYearAmt
Total$12,679,045TotalAmt

Unrelated Business Net Incm170 UnrelatedBusinessNetIncm170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$4,416CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$3,620CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$3,684CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$4,273CurrentTaxYearMinus1YearAmt
Current Tax Year$6,612CurrentTaxYearAmt
Total$22,605TotalAmt

Other Income170 OtherIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$100,852CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$121,241CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$91,510CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$524,619CurrentTaxYearMinus1YearAmt
Current Tax Year$622,113CurrentTaxYearAmt
Total$1,460,335TotalAmt
FieldValueIRS element (for citing)
Total Support$181,645,677TotalSupportAmt
Gross Receipts Rltd Activities$927,868,690GrossReceiptsRltdActivitiesAmt
Public Support CY1700.69720PublicSupportCY170Pct
Public Support PY1700.67670PublicSupportPY170Pct
Thirty Thr Pct Suprt Tests CY170Yes (X)ThirtyThrPctSuprtTestsCY170Ind

Form990 Schedule A Part VI Form990ScheduleAPartVIGrp

FieldValueIRS element (for citing)
Form And Line ReferenceSCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME:FormAndLineReferenceDesc
ExplanationPATRONAGE DIVIDENDS - 2020 AMOUNT: $ 31,405. 2021 AMOUNT: $ 0. 2022 AMOUNT: $ 0. 2023 AMOUNT: $ 0. 2024 AMOUNT: $ 0. COPY FEES - 2020 AMOUNT: $ 0. 2021 AMOUNT: $ 0. 2022 AMOUNT: $ 510. 2023 AMOUNT: $ 0. 2024 AMOUNT: $ 667. MISCELLANEOUS - 2020 AMOUNT: $ 197. 2021 AMOUNT: $ 12,241. 2022 AMOUNT: $ 0. 2023 AMOUNT: $ 355. 2024 AMOUNT: $ 3,347. ACQUIRED CASH RECEIPTS - 2020 AMOUNT: $ 69,250. 2021 AMOUNT: $ 109,000. 2022 AMOUNT: $ 91,000. 2023 AMOUNT: $ 110,000. 2024 AMOUNT: $ 66,667. CREDIT CARD REBATES - 2020 AMOUNT: $ 0. 2021 AMOUNT: $ 0. 2022 AMOUNT: $ 0. 2023 AMOUNT: $ 880. 2024 AMOUNT: $ 51. AFFILIATE SERVICE FEES - 2020 AMOUNT: $ 0. 2021 AMOUNT: $ 0. 2022 AMOUNT: $ 0. 2023 AMOUNT: $ 413,384. 2024 AMOUNT: $ 551,381.ExplanationTxt

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

FieldValueIRS element (for citing)
ContributorRESTRICTEDContributorNum

Contributor Business Name ContributorBusinessName

FieldValueIRS element (for citing)
Business Name Line1RESTRICTEDBusinessNameLine1

Contributor US Address ContributorUSAddress

FieldValueIRS element (for citing)
Address Line1RESTRICTEDAddressLine1
Address Line2RESTRICTEDAddressLine2
CityRESTRICTEDCity
StateRESTRICTEDState
ZIP CodeRESTRICTEDZIPCode
FieldValueIRS element (for citing)
Total ContributionsRESTRICTEDTotalContributionsAmt

Schedule C IRS990ScheduleC

FieldValueIRS element (for citing)
Volunteers0VolunteersInd
Paid Staff Or ManagementYes (1)PaidStaffOrManagementInd
Media Advertisements0MediaAdvertisementsInd
Mailings Members0MailingsMembersInd
Publications Or Broadcast0PublicationsOrBroadcastInd
Grants Other Organizations0GrantsOtherOrganizationsInd
Direct Contact Legislators0DirectContactLegislatorsInd
Rallies Demonstrations0RalliesDemonstrationsInd
Other ActivitiesYes (1)OtherActivitiesInd
Other Activities$66,375OtherActivitiesAmt
Total Lobbying Expenditures$66,375TotalLobbyingExpendituresAmt
Not Described Section501c30NotDescribedSection501c3Ind

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART II-B, LINE 1:FormAndLineReferenceDesc
ExplanationPAID STAFF OR MANAGMENT GENERAL COUNSEL PROVIDES LOBBYING SERVICES TO THE FILING ORGANIZATION. HOWEVER, SUCH EXPENSES ARE PAID FOR BY VERSITI INC., THE FILING ORGANIZATION'S PARENT. OTHER ACTIVITIES $8,775 OF THE DUES PAID TO THE ASSOCIATION OF ORGAN PROCUREMENT ORGANIZATIONS AND $57,600 OF OTHER EXPENSES PAID WERE ALLOCATED TO LOBBYING ACTIVITIES.ExplanationTxt

Schedule D IRS990ScheduleD

CY Endwmt Fund CYEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$104,985,040BeginningYearBalanceAmt
Contributions$784,199ContributionsAmt
Investment Earnings Or Losses$12,490,658InvestmentEarningsOrLossesAmt
Other Expenditures$4,744,538OtherExpendituresAmt
End Year Balance$113,515,359EndYearBalanceAmt

CY Minus1 Yr Endwmt Fund CYMinus1YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$94,766,972BeginningYearBalanceAmt
Contributions$671,355ContributionsAmt
Investment Earnings Or Losses$14,059,961InvestmentEarningsOrLossesAmt
Other Expenditures$4,513,248OtherExpendituresAmt
End Year Balance$104,985,040EndYearBalanceAmt

CY Minus2 Yr Endwmt Fund CYMinus2YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$112,901,289BeginningYearBalanceAmt
Contributions$848,275ContributionsAmt
Investment Earnings Or Losses-$13,361,785InvestmentEarningsOrLossesAmt
Other Expenditures$5,620,807OtherExpendituresAmt
End Year Balance$94,766,972EndYearBalanceAmt

CY Minus3 Yr Endwmt Fund CYMinus3YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$99,612,019BeginningYearBalanceAmt
Contributions$1,371,435ContributionsAmt
Investment Earnings Or Losses$16,077,669InvestmentEarningsOrLossesAmt
Other Expenditures$4,159,834OtherExpendituresAmt
End Year Balance$112,901,289EndYearBalanceAmt

CY Minus4 Yr Endwmt Fund CYMinus4YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$89,992,682BeginningYearBalanceAmt
Contributions$4,494,881ContributionsAmt
Investment Earnings Or Losses$9,457,908InvestmentEarningsOrLossesAmt
Other Expenditures$4,333,452OtherExpendituresAmt
End Year Balance$99,612,019EndYearBalanceAmt
FieldValueIRS element (for citing)
Board Designated Balance EOY0.98030BoardDesignatedBalanceEOYPct
Prmnnt Endowment Balance EOY0.01970PrmnntEndowmentBalanceEOYPct
Endowments Held Unrelated Org0EndowmentsHeldUnrelatedOrgInd
Endowments Held Related OrgYes (1)EndowmentsHeldRelatedOrgInd
Related Org List Sch RYes (1)RelatedOrgListSchRInd

Land LandGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$4,268,493OtherCostOrOtherBasisAmt
Book Value$4,268,493BookValueAmt

Buildings BuildingsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$69,535,581OtherCostOrOtherBasisAmt
Depreciation$51,296,417DepreciationAmt
Book Value$18,239,164BookValueAmt

Leasehold Improvements LeaseholdImprovementsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$2,652,452OtherCostOrOtherBasisAmt
Depreciation$1,008,230DepreciationAmt
Book Value$1,644,222BookValueAmt

Equipment EquipmentGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$49,301,473OtherCostOrOtherBasisAmt
Depreciation$36,453,151DepreciationAmt
Book Value$12,848,322BookValueAmt

Other Land Buildings OtherLandBuildingsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$14,965,166OtherCostOrOtherBasisAmt
Depreciation$934,047DepreciationAmt
Book Value$14,031,119BookValueAmt
FieldValueIRS element (for citing)
Total Book Value Land Buildings$51,031,320TotalBookValueLandBuildingsAmt

Other Securities OtherSecuritiesGrp

FieldValueIRS element (for citing)
DescINVESTMENT IN CENETRONDesc
Book Value$16,217,402BookValueAmt
Method ValuationFMethodValuationCd
FieldValueIRS element (for citing)
Total Book Value Securities$16,217,402TotalBookValueSecuritiesAmt

Other Liabilities Org OtherLiabilitiesOrgGrp (3 entries)

DescDescAmtAmt
LONG TERM RETIREMENT LIABILITIES$10,895,969
LEASE LIABILITY$3,598,811
ADDITIONAL INCENTIVES$2,219,970
FieldValueIRS element (for citing)
Total Liability$16,714,750TotalLiabilityAmt
Footnote TextYes (X)FootnoteTextInd
Total Rev Etc Audited Fincl Stmt$281,101,289TotalRevEtcAuditedFinclStmtAmt
Net Unrealized Gains Invst$999,785NetUnrealizedGainsInvstAmt
Revenue Not Reported$999,785RevenueNotReportedAmt
Revenue Subtotal$280,101,504RevenueSubtotalAmt
Investment Expenses Not Incld$5,895InvestmentExpensesNotIncldAmt
Other Revenues Not Included$912,848OtherRevenuesNotIncludedAmt
Revenue Not Reported Fincl Stmt$918,743RevenueNotReportedFinclStmtAmt
Total Revenue Per Form990$281,020,247TotalRevenuePerForm990Amt
Tot Expns Etc Audited Fincl Stmt$264,022,340TotExpnsEtcAuditedFinclStmtAmt
Other Expenses Included$387,148OtherExpensesIncludedAmt
Expenses Not Reported$387,148ExpensesNotReportedAmt
Expenses Subtotal$263,635,192ExpensesSubtotalAmt
Investment Expenses Not Incld2$5,895InvestmentExpensesNotIncld2Amt
Expenses Not Rpt Fincl Stmt$5,895ExpensesNotRptFinclStmtAmt
Total Expenses Per Form990$263,641,087TotalExpensesPerForm990Amt

Supplemental Information Detail SupplementalInformationDetail (4 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
PART V, LINE 4:ENDOWMENTS THE FILING ORGANIZATION IS A BENEFICIARY OF THE VERSITI BLOOD RESEARCH INSTITUTE FOUNDATION'S ("VBRIF") ENDOWMENT AS A SUPPORTED ORGANIZATION. THE BOARD DESIGNATED ENDOWMENT FUNDS ARE DESIGNATED BY THE BOARD AS ENDOWMENT FUNDS TO ENSURE THE CONTINUING AVAILABILITY OF FUNDS FOR RESEARCH PURPOSES.
PART X, LINE 2:INCOME TAXES VERSITI, WISCONSIN, ILLINOIS, MICHIGAN, INDIANA AND THE FOUNDATION HAVE ALL RECEIVED TAX DETERMINATION LETTERS CONFIRMING THAT THE ORGANIZATIONS QUALIFY AS TAX-EXEMPT ORGANIZATIONS UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE (IRC). THE ORGANIZATION FOLLOWS GUIDANCE THAT CLARIFIES THE ACCOUNTING FOR UNCERTAINTY IN TAX POSITIONS TAKEN OR EXPECTED TO BE TAKEN IN A TAX RETURN, INCLUDING ISSUES RELATING TO FINANCIAL STATEMENT RECOGNITION AND MEASUREMENT. THIS GUIDANCE PROVIDES THAT THE TAX EFFECTS FROM AN UNCERTAIN TAX POSITION CAN ONLY BE RECOGNIZED IN THE FINANCIAL STATEMENTS IF THE POSITION IS MORE LIKELY THAN NOT TO BE SUSTAINED IF THE POSITION WERE TO BE CHALLENGED BY A TAXING AUTHORITY. THE ASSESSMENT OF THE TAX POSITION IS BASED SOLELY ON THE TECHNICAL MERITS OF THE POSITION, WITHOUT REGARD TO THE LIKELIHOOD THAT THE TAX POSITION MAY BE CHALLENGED. VERSITI, WISCONSIN, ILLINOIS, MICHIGAN, INDIANA AND THE FOUNDATION ARE EXEMPT FROM FEDERAL INCOME TAX UNDER IRC SECTION 501(C)(3), THOUGH THEY ARE SUBJECT TO TAX ON INCOME UNRELATED TO THEIR EXEMPT PURPOSES, UNLESS THAT INCOME IS OTHERWISE EXCLUDED BY THE IRC. THE ORGANIZATION HAS PROCESSES PRESENTLY IN PLACE TO ENSURE THE MAINTENANCE OF ITS TAX-EXEMPT STATUS; TO IDENTIFY AND REPORT UNRELATED INCOME; TO DETERMINE ITS FILING AND TAX OBLIGATIONS IN JURISDICTIONS FOR WHICH IT HAS NEXUS; AND TO IDENTIFY AND EVALUATE OTHER MATTERS THAT MAY BE CONSIDERED TAX POSITIONS. THE ORGANIZATION FILES FEDERAL AND STATE INCOME TAX RETURNS TO REPORT UNRELATED BUSINESS INCOME WHERE APPLICABLE, AND WITH FEW EXCEPTIONS, THOSE PERIODS GENERALLY REMAIN OPEN THREE YEARS FOR FEDERAL PURPOSES AND FOUR YEARS FOR STATE PURPOSES. THE STATUTE OF LIMITATIONS WILL REMAIN OPEN FOR ANY YEARS WHERE RETURNS WERE NOT FILED. THE ORGANIZATION HAS DETERMINED THAT THERE ARE NO MATERIAL UNCERTAIN TAX POSITIONS THAT REQUIRE RECOGNITION OR DISCLOSURE IN THE CONSOLIDATED FINANCIAL STATEMENTS. SALUS HAS BEEN ORGANIZED AS A LIMITED LIABILITY COMPANY AND, ACCORDINGLY, IS NOT SUBJECT TO FEDERAL OR STATE INCOME TAXES. ALL INCOME TAX ATTRIBUTES OF THE ENTITY ARE PASSED THROUGH TO ITS SOLE MEMBER, WISCONSIN. THE ENTITY IS, HOWEVER, SUBJECT TO TEXAS FRANCHISE TAX. THE ENTITY IS INCLUDED IN THE CONSOLIDATED INFORMATION RETURN FILED BY VERSITI WISCONSIN. CENETRON HAS BEEN ORGANIZED AS A WHOLLY OWNED LLC THAT HAS ELECTED TO BE TREATED AS A C-CORPORATION FOR TAX PURPOSES AND SO IS SUBJECT TO FEDERAL AND STATE INCOME TAXES. INCOME TAXES ARE PROVIDED FOR THE TAX EFFECTS OF TRANSACTIONS REPORTED BY CENETRON AND CONSIST OF TAXES CURRENTLY DUE AND DEFERRED TAXES. DEFERRED TAXES ARE RECOGNIZED FOR DIFFERENCES BETWEEN THE BASIS OF ASSETS AND LIABILITIES FOR FINANCIAL STATEMENT AND INCOME TAX PURPOSES. THE DIFFERENCES RELATE PRIMARILY TO INTANGIBLE ASSETS. THE DEFERRED TAX ASSETS AND LIABILITIES REPRESENT THE FUTURE TAX RETURN CONSEQUENCES OF THOSE DIFFERENCES, WHICH WILL EITHER BE TAXABLE OR DEDUCTIBLE WHEN THE ASSETS AND LIABILITIES ARE RECOVERED OR SETTLED. CENETRON IS SUBJECT TO TAXATION IN THE UNITED STATES AND THE STATE OF TEXAS. QUANTIGEN HAS BEEN ORGANIZED AS A DISREGARDED ENTITY AND, ACCORDINGLY, IS NOT SUBJECT TO FEDERAL OR STATE INCOME TAXES. ALL INCOME TAX ATTRIBUTES OF THE ENTITY ARE PASSED THROUGH TO ITS SOLE MEMBER, WISCONSIN. PEARL PATHWAYS HAS BEEN ORGANIZED AS A DISREGARDED ENTITY AND, ACCORDINGLY, IS NOT SUBJECT TO FEDERAL OR STATE INCOME TAXES. ALL INCOME TAX ATTRIBUTES OF THE ENTITY ARE PASSED THROUGH TO ITS SOLE MEMBER, WISCONSIN. THE CONSOLIDATED DEFERRED TAX LIABILITY WAS $467,474 AND $675,285 AS OF DECEMBER 31, 2024 AND 2023, RESPECTIVELY, AND PRIMARILY RELATES TO INTANGIBLES. THERE WAS DEFERRED INCOME TAX EXPENSE FOR THE YEARS ENDED DECEMBER 31, 2024 AND 2023 OF $400,584 AND $371,200, RESPECTIVELY. THE ORGANIZATION RECOGNIZES, IF NECESSARY, INTEREST AND PENALTIES RELATED TO UNRECOGNIZED TAX BENEFITS IN THE PROVISION FOR INCOME TAXES. THERE WERE NO MATERIAL INTEREST OR PENALTIES RELATED TO INCOME TAXES THAT HAVE BEEN ACCRUED OR RECOGNIZED AS OF AND FOR THE YEARS ENDED DECEMBER 31, 2024 AND 2023.
PART XI, LINE 4B - OTHER ADJUSTMENTS:CHANGES IN EQUITY IN CENETRON -504,088. GAIN ON DISPOSITION OF FIXED ASSETS 36,770. RENTAL ACTIVITY EXPENSES -12,144. INVESTMENT IN AFFILIATE BALANCE SHEET AMOUNT 1,430,000. FUNDRAISING EXPENSES -37,690.
PART XII, LINE 2D - OTHER ADJUSTMENTS:BAD DEBT RESERVE ADJUSTMENT 374,084. GAIN ON DISPOSITION OF FIXED ASSETS -36,770. RENTAL ACTIVITY EXPENSES 12,144. FUNDRAISING EXPENSES 37,690.

Schedule G IRS990ScheduleG

Fundraising Event Information FundraisingEventInformationGrp

FieldValueIRS element (for citing)
Event1VERSITI ON KING LUNCHEvent1Nm
Gross Receipts Event1$91,734GrossReceiptsEvent1Amt
Charitable Contri Event1$65,534CharitableContriEvent1Amt
Gross Revenue Event1$26,200GrossRevenueEvent1Amt
Food And Beverage Event1$13,975FoodAndBeverageEvent1Amt
Other Direct Expenses Event1$23,715OtherDirectExpensesEvent1Amt
Gross Receipts Total$91,734GrossReceiptsTotalAmt
Charitable Contributions Tot$65,534CharitableContributionsTotAmt
Gross Revenue Total Events$26,200GrossRevenueTotalEventsAmt
Food And Beverage Total Events$13,975FoodAndBeverageTotalEventsAmt
Oth Direct Expnss Total Events$23,715OthDirectExpnssTotalEventsAmt
Direct Expense Summary Events$37,690DirectExpenseSummaryEventsAmt
Net Income Summary-$11,490NetIncomeSummaryAmt

Schedule I IRS990ScheduleI

FieldValueIRS element (for citing)
Grant Records MaintainedYes (1)GrantRecordsMaintainedInd

Recipient Table RecipientTable (4 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdRecipient EINRecipientEINIRC SectionIRCSectionDescCash GrantCashGrantAmtNon Cash AssistanceNonCashAssistanceAmtPurpose Of GrantPurposeOfGrantTxt
VERSITI BLOOD RESEARCH INSTITUTE FOUNDATION
PO BOX 2178 638 N 18TH STREETMILWAUKEEWI532012178391372542501(C)(3)$3,810,000$0RESEARCH
GREAT LAKES HEMOPHILIA FOUUNDATION INC
638 N 18TH STMILWAUKEEWI53233237367636501(C)(3)$129,750$0PATIENT FINANCIAL ASSISTANCE
MARCUS PERFORMING ARTS CENTER
929 N WATER STMILWAUKEEWI53202510532407501(C)(3)$10,000$0GENERAL SUPPORT
WISCONSIN STATE FAIR PARK FOUNDATION
640 S 84TH STWEST ALLISWI53214391840248501(C)(3)$7,000$0GENERAL SUPPORT
FieldValueIRS element (for citing)
Total501c3 Org4Total501c3OrgCnt

Grants Other Asst To Indiv In US GrantsOtherAsstToIndivInUSGrp

FieldValueIRS element (for citing)
Grant TypeSCHOLARSHIPSGrantTypeTxt
Recipient1RecipientCnt
Cash Grant$4,000CashGrantAmt
Valuation Method UsedFMVValuationMethodUsedDesc

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART I, LINE 2:FormAndLineReferenceDesc
ExplanationPROCEDURE FOR MONITORING USE OF GRANT FUNDS INSIDE U.S. VERSITI WISCONSIN CONTINUES TO PROVIDE GRANT FUNDING TO VERSITI BLOOD RESEARCH INSTITUTE FOUNDATION, INC. AND OTHER TAX-EXEMPT ORGANIZATIONS. THESE FUNDS WILL SUPPORT FUTURE BLOOD RESEARCH AND OTHER INITIATIVES TO SERVE MORE PATIENTS AND REDUCE OVERALL COSTS. MONITORING THE INVESTMENT OF THESE FUNDS, THE DISTRIBUTIONS AND WHAT THESE FUNDS ARE USED FOR IS COMPLETED BY LEADERSHIP OF VERSITI WISCONSIN. ADDITIONALLY, THE FILING ORGANIZATION OFFERS SCHOLARSHIPS TO EMPLOYEES AND COMMUNITY MEMBERS IF CERTAIN CRITERIA ARE MET. THE SCHOLARSHIPS ARE SENT TO THE COLLEGE OR UNIVERSITY WHERE THE STUDENT IS ENROLLED.ExplanationTxt

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
Compensation CommitteeYes (X)CompensationCommitteeInd
Independent ConsultantYes (X)IndependentConsultantInd
Form990 Of Other OrganizationsYes (X)Form990OfOtherOrganizationsInd
Compensation SurveyYes (X)CompensationSurveyInd
Board Or Committee ApprovalYes (X)BoardOrCommitteeApprovalInd
Severance Payment0SeverancePaymentInd
Supplemental Nonqual Rtr Plan0SupplementalNonqualRtrPlanInd
Equity Based Comp Arrngm0EquityBasedCompArrngmInd
Comp Based On Revenue Of Flng OrgYes (1)CompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related OrgsYes (1)CompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng OrgYes (1)CompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd OrgsYes (1)CompBsdNetEarnsRltdOrgsInd
Any Non Fixed PaymentsYes (1)AnyNonFixedPaymentsInd
Initial Contract Exception0InitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (19 entries)

TitleTitleTxtBase Compensation Filing OrgBaseCompensationFilingOrgAmtCompensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmtBonus Filing OrganizationBonusFilingOrganizationAmountBonus Related OrganizationsBonusRelatedOrganizationsAmtOther Compensation Filing OrgOtherCompensationFilingOrgAmtOther Compensation Rltd OrgsOtherCompensationRltdOrgsAmtDeferred Compensation Flng OrgDeferredCompensationFlngOrgAmtDeferred Comp Rltd OrgsDeferredCompRltdOrgsAmtNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmtNontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmtTotal Compensation Filing OrgTotalCompensationFilingOrgAmtTotal Compensation Rltd OrgsTotalCompensationRltdOrgsAmtComp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmtComp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
CHRIS MISKEL
PRESIDENT & CEO$350,722$446,376$352,309$448,395$10,909$13,885$10,626$13,525$14,748$18,770$739,314$940,951$0$0
BART REUTER
EVP & GENERAL COUNSEL$189,439$241,106$178,380$227,030$11,283$14,362$10,626$13,525$18,433$23,462$408,161$519,485$0$0
BRIAN BAUTISTA
EVP & CHIEF OPERATING OFFICER$204,932$260,825$143,060$182,076$9,623$12,249$8,081$10,285$15,499$19,727$381,195$485,162$0$0
ANTHONY WATKINS
EVP&CFO-THRU 3/24;BUS DEV-AS OF 3/24$144,004$183,278$155,980$198,520$29,449$37,480$10,626$13,525$2,518$3,207$342,577$436,010$0$0
MICHAEL DEININGER MD
EVP & CHIEF SCIENTIFIC OFFICER$497,386$26,178$112,195$5,905$27,499$1,447$15,090$794$22,180$1,167$674,350$35,491$0$0
BRADLEY PIETZ
EVP & CHIEF LABORATORY OFFICER$135,259$172,151$117,801$149,929$11,340$14,435$10,538$13,413$18,251$23,228$293,189$373,156$0$0
JAMES WEIDNER
EVP & CHIEF HR OFFICER$140,199$178,436$100,156$127,471$11,149$14,191$10,626$13,525$14,361$18,280$276,491$351,903$0$0
MATTHEW ANDERSON MD
EVP & CHIEF MED. OFF. - AS OF 7/24$403,926$0$65,100$0$2,842$0$24,150$0$41,700$0$537,718$0$0$0
LYNNE BRIGGS
VP & CHIEF INFORMATION OFFICER$141,179$179,684$67,763$86,243$3,078$3,919$11,595$14,758$11,558$14,711$235,173$299,315$0$0
DEREK TYUS
EVP & CHIEF FINANCIAL OFF. - AS 3/24$144,868$184,379$52,800$67,200$1,345$1,712$10,425$13,268$10,851$13,809$220,289$280,368$0$0
KATHLEEN PUCA
SR MEDICAL DIRECTOR$345,435$0$67,100$0$30,022$0$27,600$0$27,900$0$498,057$0$0$0
BARBARA BRYANT
EVP & CHIEF MED. OFF. - THRU 8/24$328,620$0$101,700$0$17,502$0$23,946$0$1,902$0$473,670$0$0$0
CHRISTIAN J KASTRUP PHD
SR INVESTIGATOR$377,833$0$19,900$0$1,486$0$20,250$0$41,632$0$461,101$0$0$0
KARIN HOFFMEISTER
DEPUTY DIRECTOR VBRI$353,991$0$41,800$0$15,255$0$14,309$0$35,019$0$460,374$0$0$0
LISA BAUMANN KREUZIGER
SENIOR MEDICAL DIRECTOR$345,859$0$23,800$0$25,277$0$24,150$0$16,428$0$435,514$0$0$0
GITESH DUBAL
EVP & CHIEF MKTG. OFF. - THRU 4/24$56,655$72,103$113,676$144,678$8,777$11,171$4,651$5,920$5,813$7,397$189,572$241,269$0$0
LYNN M MALEC MD
SENIOR MEDICAL DIRECTOR$361,479$0$18,100$0$4,668$0$17,926$0$16,964$0$419,137$0$0$0
JESSICA DROUILLARD
VP & CHIEF QUALITY OFFICER$86,807$110,482$24,376$31,024$10,272$13,076$6,776$8,624$1,543$1,962$129,774$165,168$0$0
GRETCHEN JAMESON
EVP & CHIEF MKTG. OFF. - AS OF 4/24$96,463$122,769$0$0$520$663$6,042$7,689$563$719$103,588$131,840$0$0

Supplemental Information Detail SupplementalInformationDetail (2 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
PART I, LINE 3TOP MANAGEMENT'S COMPENSATION THE EXECUTIVE COMMITTEE OF THE BOARD OF DIRECTORS, ACTING IN ITS CAPACITY AS THE COMPENSATION COMMITTEE, SETS AND MONITORS THE COMPENSATION PHILOSOPHY FOR THE FILING ORGANIZATION. OTHER THAN THE VERSITI PRESIDENT AND CHIEF EXECUTIVE OFFICER, THE EXECUTIVE COMMITTEE DOES NOT INCLUDE MEMBERS OF MANAGEMENT. TO ENSURE THAT THE COMMITTEE IS COMPRISED OF INDIVIDUALS WHO DO NOT HAVE A CONFLICT OF INTEREST WITH RESPECT TO VERSITI COMPENSATION ARRANGEMENTS, THE VERSITI PRESIDENT AND CHIEF EXECUTIVE OFFICER RECUSES HER/HIMSELF FROM ALL DISCUSSIONS AND APPROVALS RELATED TO HER/HIS COMPENSATION. THE EXECUTIVE COMMITTEE REVIEWS EXECUTIVE COMPENSATION ARRANGEMENTS TO ENSURE SUCH ARRANGEMENTS ARE FAIR, REASONABLE, AND NOT EXCESSIVE WHEN COMPARED TO SIMILARLY-SITUATED EXECUTIVES. EXECUTIVE COMPENSATION ARRANGEMENTS ARE REVIEWED FOR REASONABLENESS AND APPROVED BY THE EXECUTIVE COMMITTEE ANNUALLY IN ACCORDANCE WITH THE VERSITI REASONABLENESS REVIEW POLICY. IN ORDER TO ASSESS THE REASONABLENESS OF EXECUTIVE COMPENSATION ARRANGEMENTS, THE EXECUTIVE COMMITTEE OBTAINS AND REVIEWS APPROPRIATE COMPARABILITY DATA COLLECTED BY THE HUMAN RESOURCE DEPARTMENT AND/OR A QUALIFIED INDEPENDENT COMPENSATION CONSULTANT. THE EXECUTIVE COMMITTEE ENGAGES A QUALIFIED INDEPENDENT COMPENSATION CONSULTANT ANNUALLY. THE INDEPENDENT CONSULTANT PERFORMS AN ANALYSIS OF COMPENSATION LEVELS AT REGIONAL AND NATIONAL ORGANIZATIONS OF COMPARABLE SIZE, SCOPE AND STRUCTURE; AND PROVIDES THE COMMITTEE WITH COMPREHENSIVE DATA ON THE AVAILABILITY OF SIMILAR SERVICES WITHIN THE GEOGRAPHIC AREA, COMPENSATION SURVEYS, WRITTEN OFFERS FROM SIMILAR INSTITUTIONS, AND OTHER INFORMATION RELEVANT TO COMPARABILITY OF COMPENSATION. THE EXECUTIVE COMMITTEE'S REVIEW, RECOMMENDATIONS AND APPROVALS ARE DOCUMENTED CONCURRENTLY IN THE COMMITTEE MINUTES, WHICH ARE SUBSEQUENTLY REVIEWED AND APPROVED BY THE EXECUTIVE COMMITTEE AS REASONABLE, ACCURATE AND COMPLETE. THE COMMITTEE CHAIR VERBALLY COMMUNICATES TO THE BOARD OF DIRECTORS A CONFIRMATION OF COMPENSATION REASONABLENESS AND THE OVERALL DUE DILIGENCE PROCESS. VERSITI WISCONSIN HAS INCENTIVE PROGRAMS FOR EXECUTIVES, DIRECTORS, MANAGEMENT, INVESTIGATORS AND STAFF DESCRIBED IN DETAILED WRITTEN POLICIES APPROVED BY THE EXECUTIVE COMMITTEE ANNUALLY. EVALUATION AND COMPENSATION REVIEW -CEO - EACH YEAR, THE EXECUTIVE COMMITTEE EVALUATES THE CEO'S PERFORMANCE AGAINST ESTABLISHED OBJECTIVES, DETERMINES INCENTIVE PAYMENT AND MERIT INCREASE BASED UPON PERFORMANCE AND MARKET DATA PROVIDED BY THE THIRD PARTY COMPENSATION CONSULTANT, AND WORKS WITH THE CEO TO ESTABLISH OBJECTIVES FOR THE NEXT YEAR. -EXECUTIVES - THE BOARD OF DIRECTORS HAS DELAGATED TO THE CEO THE PERFORMANCE ASSESSMENT AND COMPENSATION DECISIONS FOR HIS/HER TEAM AND LEADERS ELIGIBLE FOR THE VERSITI LEADERSHIP INCENTIVE PLAN. DURING THE MAY MEETING, THE EXECUTIVE COMMITTEE REVIEWS THE INCENTIVES (SHORT AND LONG-TERM) PAYOUTS AND MERIT INCREASES ASSIGNED TO THE EXECUTIVE TEAM AS PART OF THE ANNUAL COMPENSATION REASONABILITY REVIEW CONDUCTED BY AON CONSULTANTS. THE EXECUTIVE COMMITTEE REVIEWS AND APPROVES THE SALARY INCREASES AND INCENTIVE PAYOUTS OF THE CEO BEFORE PAYMENT. EXECUTIVES ARE POSITIONED WITHIN THE APPROPRIATE SALARY RANGE BASED UPON THE: -EXECUTIVE'S KNOWLEDGE, COMPETENCIES, AND EXPERIENCE, -PERFORMANCE OF THE EXECUTIVE'S AREAS OF RESPONSIBILITY, -THE EXECUTIVE'S CONTRIBUTION TO OVERALL PERFORMANCE, -THE IMPORTANCE OF RETAINING THE EXECUTIVE, -INTERNAL EQUITY CONSIDERATIONS, -THE FINANCIAL RESOURCES AVAILABLE, AND -EXECUTIVE BASE SALARY INCREASES PROVIDED IN THE COMPETITIVE MARKET.
PART I, LINE 5A, 5B, 6A, 6B AND 7:NON-FIXED PAYMENTS INCENTIVE PAYOUT OPPORTUNITIES, BASED ON PERCENTAGE OF BASE PAY RATE, ARE AVAILABLE TO CERTAIN EMPLOYEES OF THE FILING ORGANIZATION. WHILE LEVELS OF THE INCENTIVE PAYOUT OPPORTUNITY ARE FIXED AND DETERMINED PERCENTAGES OF BASE COMPENSATION, THE INCENTIVE PAYOUT IS DETERMINED, IN PART, ON THE CONSOLIDATED REVENUE AND NET EARNINGS OF OPERATING DIVISIONS. THE INCENTIVE PAYOUT IS SUBJECT TO THE REVIEW OF ACCOMPLISHMENTS/OBJECTIVES AND THE ULTIMATE DETERMINATION OF INCENTIVE COMPENSATION IS SUBJECT TO PRESIDENT/CEO AND EXECUTIVE COMMITTEE OF THE BOARD APPROVAL.

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (11 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
FORM 990, PART I, LINE 1VERSITI WISCONSIN, INC. (VERSITI WISCONSIN) IS A BLOOD HEALTH INNOVATOR WHICH ENHANCES LIVES THROUGH DISCOVERY, DIAGNOSIS AND TREATMENT. VERSITI EXPANDS THE FRONTIERS OF PATIENT HEALTH THROUGH THE INTEGRATION OF SCIENCE, MEDICINE AND SERVICE.
FORM 990, PART VI, SECTION A, LINE 6MEMBERS OR STOCKHOLDERS VERSITI, INC. IS THE SOLE CORPORATE MEMBER.
FORM 990, PART VI, SECTION A, LINE 7AMEMBER OR STOCKHOLDER POWERS VERSITI, INC. HAS RESERVE POWERS; INCLUDING THE ABILITY TO ELECT A MAJORITY OF DIRECTORS.
FORM 990, PART VI, SECTION A, LINE 7BREFER TO NARRATIVE LISTED IN LINE 7A.
FORM 990, PART VI, SECTION B, LINE 11BFORM 990 REVIEW VERSITI WISCONSIN UTILIZES GRANT THORNTON TO COMPLETE THE IRS FORM 990 AND RELATED SCHEDULES. FOLLOWING COMPLETION, THEY ARE REVIEWED BY THE ORGANIZATION'S MANAGEMENT. THE DRAFT FORMS ARE THEN REVIEWED BY THE AUDIT AND COMPLIANCE COMMITTEE PRIOR TO SUBMISSION TO THE IRS. THE FULL BOARD IS PROVIDED A COPY OF THE FORM 990 PRIOR TO FILING.
FORM 990, PART VI, SECTION B, LINE 12CCONFLICT OF INTEREST POLICY VERSITI WISCONSIN MAINTAINS A WRITTEN CONFLICT OF INTEREST POLICY. ON AN ANNUAL BASIS, CURRENT DIRECTORS AND OFFICERS ARE ASKED TO COMPLETE A DISCLOSURE FORM BASED ON IRS REQUIREMENTS THAT INCLUDES THE FOLLOWING: WHETHER THEY HAVE ANY DIRECT OR INDIRECT RELATIONSHIP EITHER THROUGH BUSINESS OR FAMILY MEMBER WITH THE ORGANIZATION. WHETHER THEY RECEIVED COMPENSATION FROM ANY ORGANIZATION THAT SHARES COMMON OWNERSHIP OR CONTROL WITH THE ORGANIZATION. WHETHER THEY HAVE SERVED AS AN OFFICER, DIRECTOR, KEY EMPLOYEE, PARTNER OR MEMBER OF AN ENTITY (OR SHAREHOLDER OF A PROFESSIONAL CORPORATION) DOING BUSINESS WITH THE ORGANIZATION. THESE ANSWERS ARE ACCUMULATED, SUMMARIZED AND EVALUATED BY MANAGEMENT TO DETERMINE IF ANY CONFLICTS EXIST. IDENTIFIED CONFLICTS ARE ADDRESSED IN ACCORDANCE WITH THE WRITTEN POLICY.
FORM 990, PART VI, SECTION B, LINE 15COMPENSATION PROCESS THE EXECUTIVE COMMITTEE OF THE BOARD OF DIRECTORS, ACTING IN ITS CAPACITY AS THE COMPENSATION COMMITTEE, SETS AND MONITORS THE COMPENSATION PHILOSOPHY FOR THE FILING ORGANIZATION.
FORM 990, PART VI, SECTION C, LINE 19ORGANIZATION'S DOCUMENTS OPEN TO THE PUBLIC THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE UPON REQUEST TO THE PUBLIC DURING NORMAL BUSINESS HOURS AND AT THE ORGANIZATION'S LOCATION.
PART VII:AVERAGE HOURS THE HOURS LISTED ON FORM 990, PART VII ARE REPRESENTATIVE OF AN AVERAGE FOR THE OFFICERS AND EXECUTIVE TEAM. EACH INDIVIDUAL PERSON'S WEEKLY TALLY MAY BE GREATER OR LESSER PER WEEK BASED ON THEIR INDIVIDUAL ROLES AND RESPONSIBILITIES WITHIN THE FILING ORGANIZATION AND RELATED PARTIES.
FORM 990, PART IX, LINE 11GSHIPPING & TRANSPORTATION: PROGRAM SERVICE EXPENSES 1,892,601. MANAGEMENT AND GENERAL EXPENSES 164,068. TOTAL EXPENSES 2,056,669. OUTSIDE LAB SERVICE: PROGRAM SERVICE EXPENSES 547,086. TOTAL EXPENSES 547,086. TEMPORARY HELP: PROGRAM SERVICE EXPENSES 445,420. MANAGEMENT AND GENERAL EXPENSES -40,335. TOTAL EXPENSES 405,085. SUBAWARDS: PROGRAM SERVICE EXPENSES 5,782,955. TOTAL EXPENSES 5,782,955. DONOR TESTING: PROGRAM SERVICE EXPENSES 5,744,886. TOTAL EXPENSES 5,744,886. PURCHASED SERVICES: PROGRAM SERVICE EXPENSES 1,255,534. MANAGEMENT AND GENERAL EXPENSES 495,400. TOTAL EXPENSES 1,750,934. ANIMAL CARE COSTS: PROGRAM SERVICE EXPENSES 1,331,489. TOTAL EXPENSES 1,331,489. CONSULTING SERVICES: PROGRAM SERVICE EXPENSES 1,353,566. MANAGEMENT AND GENERAL EXPENSES 56,399. TOTAL EXPENSES 1,409,965. OPERATING ROOM: PROGRAM SERVICE EXPENSES 1,163,168. TOTAL EXPENSES 1,163,168. IRB CONTRACTOR FEES: PROGRAM SERVICE EXPENSES 866,757. TOTAL EXPENSES 866,757. LAB: PROGRAM SERVICE EXPENSES 617,231. TOTAL EXPENSES 617,231. ICU: PROGRAM SERVICE EXPENSES 587,028. TOTAL EXPENSES 587,028. TRANSLATION SERVICE: PROGRAM SERVICE EXPENSES 491,172. TOTAL EXPENSES 491,172. PHARMACY: PROGRAM SERVICE EXPENSES 478,584. TOTAL EXPENSES 478,584. OTHER HOSPITAL CHARGES: PROGRAM SERVICE EXPENSES 386,278. TOTAL EXPENSES 386,278. GRADUATE STUDENT STIPENDS: PROGRAM SERVICE EXPENSES 363,637. TOTAL EXPENSES 363,637. RADIOLOGY: PROGRAM SERVICE EXPENSES 353,846. TOTAL EXPENSES 353,846. CLAIM/BILLING REVIEW: PROGRAM SERVICE EXPENSES 343,423. TOTAL EXPENSES 343,423. OUTSIDE MEDICAL DIRECTOR (OPO): PROGRAM SERVICE EXPENSES 338,895. TOTAL EXPENSES 338,895. CARDIOLOGY: PROGRAM SERVICE EXPENSES 309,386. TOTAL EXPENSES 309,386. FACILITY CHARGES: PROGRAM SERVICE EXPENSES 249,890. TOTAL EXPENSES 249,890. RESPIRATORY THERAPY: PROGRAM SERVICE EXPENSES 203,332. TOTAL EXPENSES 203,332. RECORD STORAGE: PROGRAM SERVICE EXPENSES 8,645. MANAGEMENT AND GENERAL EXPENSES 193,876. TOTAL EXPENSES 202,521. PHYSICIAN FEES: PROGRAM SERVICE EXPENSES 177,046. TOTAL EXPENSES 177,046. ANESTHESIA: PROGRAM SERVICE EXPENSES 159,955. TOTAL EXPENSES 159,955. LICENSES, PERMITS, & HOSP FEES: PROGRAM SERVICE EXPENSES 109,085. MANAGEMENT AND GENERAL EXPENSES 5,733. TOTAL EXPENSES 114,818. EDUCATION: PROGRAM SERVICE EXPENSES 73,611. MANAGEMENT AND GENERAL EXPENSES 33,663. TOTAL EXPENSES 107,274. DNA SEQUENCING: PROGRAM SERVICE EXPENSES 91,053. TOTAL EXPENSES 91,053. FUNERAL HOME CHARGES: PROGRAM SERVICE EXPENSES 85,305. TOTAL EXPENSES 85,305. PS SUPPLIES: PROGRAM SERVICE EXPENSES 84,572. TOTAL EXPENSES 84,572. CUSTOMER TESTING: PROGRAM SERVICE EXPENSES 54,813. TOTAL EXPENSES 54,813. PUBLICATION SERVICES: PROGRAM SERVICE EXPENSES 49,888. MANAGEMENT AND GENERAL EXPENSES 3,018. TOTAL EXPENSES 52,906. NON-MARKETING PRINTING COSTS : PROGRAM SERVICE EXPENSES 29,435. MANAGEMENT AND GENERAL EXPENSES 3,967. TOTAL EXPENSES 33,402. OUTSIDE CORE LAB CHARGES: PROGRAM SERVICE EXPENSES 25,836. TOTAL EXPENSES 25,836. OTHER PURCHASE SERV AFFILIATES: PROGRAM SERVICE EXPENSES 16,541. TOTAL EXPENSES 16,541. NON-HOSPITAL BUSINESS DEVELOPMENT: PROGRAM SERVICE EXPENSES 14,538. TOTAL EXPENSES 14,538. PHARMACY DISPENSING FEE: PROGRAM SERVICE EXPENSES 12,635. TOTAL EXPENSES 12,635. BANK ACCOUNT FEES: PROGRAM SERVICE EXPENSES 9,223. MANAGEMENT AND GENERAL EXPENSES 1,816. TOTAL EXPENSES 11,039. LAUNDRY COSTS: PROGRAM SERVICE EXPENSES 8,846. TOTAL EXPENSES 8,846. VARIABLE LEASES PRINTING SERVICES: MANAGEMENT AND GENERAL EXPENSES 588. TOTAL EXPENSES 588. MEDICAL REPORTS: PROGRAM SERVICE EXPENSES 79. TOTAL EXPENSES 79. EMPLOYMENT RECRUITMENT FEES: PROGRAM SERVICE EXPENSES 20. TOTAL EXPENSES 20.
FORM 990, PART XI, LINE 9:BAD DEBT RESERVE ADJUSTMENT -374,084. CHANGE IN EQUITY IN CENETRON 504,088. INVESTMENT IN AFFILIATE BALANCE SHEET AMOUNT -1,430,000.

Schedule R IRS990ScheduleR

Id Disregarded Entities IdDisregardedEntitiesGrp (3 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdEINEINPrimary ActivitiesPrimaryActivitiesTxtLegal Domicile StateLegalDomicileStateCdTotal IncomeTotalIncomeAmtEnd Of Year AssetsEndOfYearAssetsAmtBusiness Name Line1DirectControllingEntityName/BusinessNameLine1Txt
RCRC INDEPENDENT REVIEW BOARD LLC
2111 W BRAKER LANE SUITE 100AUSTINTX78758390807235REVIEW BOARDTX$5,691,154$4,567,553VERSITI WI
QUANTIGEN LLC
10300 KINCAID DR STE 200FISHERSIN46037260229477SPECIALTY LAB SERVICESIN$8,575,322$22,717,169VERSITI WI
PEARL IRB LLC
29 E MCCARTY ST STE 100INDIANAPOLISIN46225271927520REGULATORY AFFAIRS CONSULTING SERVICESIN$3,994,527$11,401,801VERSITI WI

Id Related Tax Exempt Org IdRelatedTaxExemptOrgGrp (5 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdEINEINPrimary ActivitiesPrimaryActivitiesTxtLegal Domicile StateLegalDomicileStateCdExempt Code SectionExemptCodeSectionTxtPublic Charity StatusPublicCharityStatusTxtBusiness Name Line1DirectControllingEntityName/BusinessNameLine1TxtControlled OrganizationControlledOrganizationIndDirect Controlling NADirectControllingNACd
VERSITI BLOOD RESEARCH INSTITUTE FNDN
PO BOX 2178 638 N 18TH STMILWAUKEEWI53201391372542SUPPORTINGWI501(C)(3)LINE 12B, IIVERSITI0
VERSITI INC
PO BOX 2178 638 N 18TH STMILWAUKEEWI53201454675354SUPPORTINGWI501(C)(3)LINE 12B, II0N/A
VERSITI ILLINOIS INC
1200 N HIGHLAND AVEAURORAIL60506362179768BLOODIL501(C)(3)LINE 10VERSITI0
VERSITI MICHIGAN INC
1036 FULLER AVE NEGRAND RAPIDSMI49503381550001BLOODMI501(C)(3)LINE 10VERSITI0
VERSITI INDIANA INC
3450 N MERIDIAN STINDIANAPOLISIN46208350991629BLOODIN501(C)(3)LINE 10VERSITI0

Id Related Org Txbl Corp Tr IdRelatedOrgTxblCorpTrGrp

Related Organization Name RelatedOrganizationName

FieldValueIRS element (for citing)
Business Name Line1CENETRON DIAGNOSTICS LLCBusinessNameLine1Txt

US Address USAddress

FieldValueIRS element (for citing)
Address Line12111 W BRAKER LANE SUITE 300AddressLine1Txt
CityAUSTINCityNm
State AbbreviationTXStateAbbreviationCd
ZIP78758ZIPCd
FieldValueIRS element (for citing)
EIN742760677EIN
Primary ActivitiesLABS & TRIALSPrimaryActivitiesTxt
Legal Domicile StateTXLegalDomicileStateCd

Direct Controlling Entity Name DirectControllingEntityName

FieldValueIRS element (for citing)
Business Name Line1VERSITI WIBusinessNameLine1Txt
FieldValueIRS element (for citing)
Entity TypeCEntityTypeTxt
Share Of Total Income$504,088ShareOfTotalIncomeAmt
Share Of EOY Assets$20,800,182ShareOfEOYAssetsAmt
Ownership1.00000OwnershipPct
Controlled OrganizationYes (1)ControlledOrganizationInd
FieldValueIRS element (for citing)
Receipt Of Int Annts Rnts Rylts0ReceiptOfIntAnntsRntsRyltsInd
Gift Grnt Or Cap Contri To Oth OrgYes (1)GiftGrntOrCapContriToOthOrgInd
Gift Grnt Cap Contri From Oth OrgYes (1)GiftGrntCapContriFromOthOrgInd
Loans Or Guarantees To Other Org0LoansOrGuaranteesToOtherOrgInd
Loans Or Guarantees From Oth Org0LoansOrGuaranteesFromOthOrgInd
Div Related OrganizationYes (1)DivRelatedOrganizationInd
Asset Sale To Other OrgYes (1)AssetSaleToOtherOrgInd
Asset Purchase From Other OrgYes (1)AssetPurchaseFromOtherOrgInd
Asset Exchange0AssetExchangeInd
Rental Of Facilities To Oth Org0RentalOfFacilitiesToOthOrgInd
Rental Of Fclts From Oth OrgYes (1)RentalOfFcltsFromOthOrgInd
Perform Of Services For Oth OrgYes (1)PerformOfServicesForOthOrgInd
Perform Of Services By Other OrgYes (1)PerformOfServicesByOtherOrgInd
Sharing Of FacilitiesYes (1)SharingOfFacilitiesInd
Paid Employees SharingYes (1)PaidEmployeesSharingInd
Reimbursement Paid To Other OrgYes (1)ReimbursementPaidToOtherOrgInd
Reimbursement Paid By Other OrgYes (1)ReimbursementPaidByOtherOrgInd
Transfer To Other Org0TransferToOtherOrgInd
Transfer From Other Org0TransferFromOtherOrgInd

Transactions Related Org TransactionsRelatedOrgGrp (6 entries)

Transaction TypeTransactionTypeTxtInvolvedInvolvedAmtMethod Of Amount DeterminationMethodOfAmountDeterminationTxt
CENETRON DIAGNOSTICS LLC
F$1,430,000FMV
CENETRON DIAGNOSTICS LLC
K$194,293FMV
CENETRON DIAGNOSTICS LLC
L$27,260FMV
CENETRON DIAGNOSTICS LLC
M$209,428FMV
CENETRON DIAGNOSTICS LLC
P$196,806FMV
CENETRON DIAGNOSTICS LLC
Q$351,288FMV